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Abstract 
 
One of the last frontiers to conquer in infertility research is to find a treatment for uterine 
factor infertility, which affects around 2500 Swedish women. These women cannot 
become pregnant or carry a pregnancy due to absence of uterus or presence of non-
functioning uterus. During recent years, several animal models have been used in research 
to develop uterus transplantation into a clinical treatment for uterine factor infertility. In 
the present study, the rat was used as a uterus transplantation model to look at various 
aspects of the procedure.  
 
A first model for uterus transplantation in the rat, with vascular anastomosis, was 
developed. In this model, the native uterus was compared to a heterotopically placed 
grafted uterus within the same strain of inbred rats. There was good viability of the tissue 
and an untrained surgeon could master the procedure after around 20-30 surgeries. 
  
In the second study, the uterus transplantation model was modified further to allow for 
spontaneous mating and test of pregnancy. Pregnancy was achieved after natural mating 
and the number of pups and growth trajectory of the pups in this model was similar to that 
of controls. 
 
In tests of allogeneic uterus transplantation, effects of immunosuppression were 
evaluated. Transplanted rats received either no treatment or tacrolimus as monotherapy. 
One sham-surgery group and one sham-group treated with tacrolimus were included as 
controls. It was shown that rejection occurred in the non-tacrolimus treated transplanted 
group but that normal uterine morphology was seen in the tacrolimus treated transplanted 
group. Low numbers of T-cells were seen in most allografts treated with tacrolimus. 
Levels of the cytokines IL-1 and IP-10 were increased in the non-treated transplanted 
group and levels of the implantation marker galectin-1 were normalized after tacrolimus 
treatment. 
 
Different sites of diagnosis of rejection were tested. In a fully allogeneic model, the 
histology of the graft was analysed at day 4 or 7. On day 4, morphological signs of early 
rejection were found both in the myometrium, endometrium, uterine cervix and in the 
blood vessels. Inflammation with primarily neutrophils and lymphocytes was seen. At 
day 7, the inflammation was greater with also focal hemorrhage. It can be concluded that 
early events of rejection in a uterus transplantation model is seen in all the examined 
compartments and the cervix may be an appropriate site for clinical diagnosis of early 
rejection. 
 
The most important functional issue to test in uterus transplantation is whether uterine 
allografts can carry a pregnancy. Rats with allogeneic uterine transplants were treated 
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with tacrolimus. The pregnancy rate was similar in the transplanted and tacrolimus-
treated group as in the control groups. These experiments ended during late gestation and 
no further follow-up of the pregnancy was performed.  
 
In a follow-up paper of allogeneic transplantation, the pregnancies went to term. Birth 
weight was similar in the transplanted group that was treated with tacrolimus as in the 
control groups. The post-natal growth up to 100 days was also similar, but with somewhat 
larger weight for males born from the uterus transplanted group. 
 
In summary, the thesis presents important background data for further development of 
uterus transplantation towards clinical introduction.  
 
Keywords: infertility, microsurgery, pregnancy, rat, transplantation, uterus 
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Introduction 
 
During the last 25 years, transplantation surgery and reproductive medicine have been 
particularly inventive clinical areas. In transplantation surgery, introductions of 
transplantation of organs/tissues, that have the potential to greatly enhance the quality-of-
life of patients rather than being types of organs that are necessary for a continued life, 
have taken place. Examples of these novel types of procedures are transplantations of the 
hand, larynx, lower limb and the face (1). In reproductive medicine, several new 
techniques in the area of assisted reproduction techniques have followed the introduction 
of in vitro fertilization (IVF). The first IVF baby was born almost 35 years ago and the 
research behind this revolutionary infertility treatment was acknowledged by awarding 
the Nobel Prize in physiology and medicine in 2011 to Bob Edwards. The groups of 
infertile women that today, in spite of these developments in reproductive medicine, are 
untreatable are those that are irreversibly infertile due to uterine cause. The theme of this 
thesis is research on uterus transplantation (UTx), which is a type of transplantation 
procedure which may provide a chance for these women to carry their own child 
throughout pregnancy, but only if research paves the way for its clinical introduction.  
 
 
General infertility 
The inability to conceive a child is an important negative quality-of-life aspect for most 
women (2) and infertility is also categorized by WHO as a disease. A couple has met the 
criteria of being infertile if the woman has not become pregnant after 2 years of regular 
intercourse with no use of contraception. In many societies, including most parts of the 
western world, the term infertility usually refers to a 12 months involuntarily 
childlessness after contraceptive-free intercourse 
 
Infertility is generally divided into primary infertility, when there has never been a child 
born within a couple, and secondary infertility, when there is a failure to conceive 
following a previous pregnancy within the couple. It is problematical to exactly estimate 
the prevalence of infertility, but involuntarily childlessness is usually estimated to be 
present among around 15% of all couples (3). It is stated that around 30% of the infertility 
causes are due to male factor and 30% to female factor. Around 10-15% of causes are due 
to combined factors in both male and female and the rest are still categorised as 
unexplained infertility.  
 
Male factor infertility (4) is due to either poor sperm quality or low sperm count, which is 
usually the case after an obstruction of male reproductive duct.  
 
Female infertility can be due to dysfunction on either the hypothalamic/pituitary level, the 
ovarian level or the uterine/cervical/vaginal level. Examples of rather common 
9 
 
hypothalamic/pituitary and ovarian disorders causing female infertility are 
hyperprolactinemia and polycystic ovarian syndrome. They usually cause infertility since 
they give rise to ovulatory failure. Beside these ovulatory disorders, the most common 
causes of female factor infertility is tubal factor infertility, which occurs in around 26% of 
all infertile women, endometriosis in about 4% of all infertile women, mucus 
abnormalities in around 4% of all infertile women and genital tract disorders in around 
4% (5). Most of these causes of infertility as mentioned above are today treatable.  
 
 
Uterine factor infertility  
The type of infertility, which today is largely non treatable is uterine factor infertility. 
This group includes those women that have no uterus at all or those with a uterus but 
which is not functioning properly in terms of pregnancy potential. Infertility could also be 
defined as result of either structural or functional disorder of the uterus. 
 
Uterine factor infertility is relatively uncommon in comparison with other groups of 
infertility, but since no treatment has been available the accumulated numbers of these 
patients of fertile age is relatively high. Thus, in the United Kingdom, with a population 
of more than 60 million people, there exist an estimated 14000 uterine factor infertile 
patients (6), and this figure would correspond to around 2300 in Sweden and around 160 
000 uterine factor infertile women in Europe.  
 
The largest group of women with uterine factor infertility is most likely those that have 
been hysterectomized, which during the fertile period may be performed because of 
malignancy, leiomyoma or as a life-saving procedure at intractable obstetric bleeding, 
secondary to uterus atony or malplacentation. In an IVF-surrogate program in USA, 
around half of the enrolled women with uterine infertility had been hysterectomized (7), 
indicating the considerable size of these hysterectomized women among the uterine factor 
infertile patients.  
 
One cause of hysterectomy during fertile age is cervical cancer, which worldwide is the 
most common gynaecological malignancy (8), but lower incidences are seen in countries 
with cervical cytology screening programs. Around 30-40% of cervical cancer patients 
are of fertile age at diagnosis (8, 9). Tumors of low stage can be treated by uterine-sparing 
surgery (conization, trachelectomy) but radical hysterectomy is the recommended 
treatment for larger stage Ib and stage IIa tumors. The ovaries can be spared in squamous 
cell carcinoma of the cervix because the risk of ovarian metastasis is very low. 
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pregnancy takes place the rate of spontaneous abortion is around 40% (24). Intrauterine 
adhesions can to some extent be treated by hysteroscopic adhesiolysis, with postsurgical 
fertility in around 90%, 70% and 30% of preoperative mild, moderate and severe 
intrauterine adhesions, respectively (25).  
 
One larger group of uterine factor infertile patients are those with Müllerian duct 
anomalies. The Müllerian ducts are of mesodermal origin and are primordial roots of the 
internal female reproductive organs. They differentiate to form the Fallopian tubes, 
uterus, uterine cervix and the upper 1/3 of the vagina during fetal life.  
 
In a large study by Grimbizis and colleagues, data from multiple studies on uterine 
anomalies including more than 3000 patients calculated the incidence of uterine 
malformation in the general population to be around 4.3% (26). The incidence of 
Müllerian duct anomalies is probably somewhat higher in women with infertility and in 
those having recurrent spontaneous abortion incidences of up to 15% have been reported 
(27, 28). In a study of more than 2000 girls undergoing ultrasound examination the 
presence of uterine anomalies was around 4/1000 women (29).  
 
The American Fertility Society has classified the Müllerian anomalies into 7 specific 
groups, where group 1-6 are due to genetic or epigenetic causes and group 7 is related to 
fetal exposure to diethylstilbestrol. Clinical diagnosis of the anomalies is often carried out 
with a combination of clinical examination, ultrasound, laparoscopy and magnetic 
resonance imaging (30). 
 
The most prevalent type of structural congenital uterine anomaly among infertile women 
is the septate uterus (31), which is the result of incomplete resorption of the central parts 
of the Müllerian ducts after fusion. The septate uterus makes up around 1/3 of all uterine 
malformations (26). Spontaneous abortion is seen in about 80% of pregnancies in 
untreated septate uteri (32). Hysteroscopic resection is however an effective treatment 
that substantially decreases the rate of spontaneous abortion (32). Even so, a small 
proportion of patients with surgically treated uterine septate will still remain infertile (33). 
 
The second most common type of Müllerian duct anomaly is the bicornuate uterus, where 
disturbed fusion of the Müllerian ducts gives rise to bilaterally fully developed uterine 
horns with a single cervix and vagina. The malformation represents around 1/4 of all 
uterine malformations (26). The rate of spontaneous abortion among women with 
bicornuate uteri is around 35% (34). Surgery may normalize the increased rate of 
spontaneous abortions (35), but a large number of women with bicornuate uteri will not 
be able to carry a pregnancy to the second or third trimester.  
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Emergency peripartum hysterectomy is performed to save the life of the mother in 
situations of severe bleeding due to uterine rupture/atony, invasive malplacentation or 
uncontrolled bleeding at caesarean section. The incidence of hysterectomy at delivery is 
around 5 in 10 000 deliveries (10). It is likely that this rate will increase in the future due 
to the escalating number of women having caesarean section.  
 
Another cause of hysterectomy at fertile age is large or inoperable leiomyoma. However, 
as discussed further below most leiomyoma are small and do not cause any symptoms and 
if they are symptomatic, only the leiomyoma may be removed without removing the 
entire uterus. The prevalence of uterine leiomyoma increases with age (11). There exist 
reports of prevalence figures among reproductive-aged women of selected populations, as 
high as 20-40% (12). However, a more true prevalence may be that of around 5.5%, 
which was reported in a random sample of more than 300 Swedish women between 25 
and 40 years of age (13). In that study, a higher prevalence (8%) was seen in the subgroup 
of older women between 33 and 40 years of age. In the United States, a comparable 
prevalence was seen in Caucasian women but with a 2-fold higher prevalence in Afro-
American woman (14). In the United States, approximately 1% of all women between 30 
and 34 years and around 2.5 % of those between 35 and 39 years have been 
hysterectomized due to leiomyoma (15). This is naturally one group of leiomyoma-related 
uterine factor infertility. However, more often leiomyoma will lead to infertility in a 
woman that still has her uterus (16, 17). It is difficult to exactly understand the causation 
between presence of leiomyoma and pregnancy outcome. It may be that there is a 
structural cause, with the leiomyoma preventing implantation and pregnancy progression 
by its physical size or placement within the uterus but also biochemical local factors have 
been suggested to contribute to leiomyoma-related infertility (18). In a thorough review 
of a large IVF population it was shown that it may be that larger sized myoma (> 4 cm) 
that may decrease fertility (19). Moreover, smaller subendometrial myoma may be a 
factor behind uterine factor infertility. 
 
Some of this leiomyoma-related infertility can be surgically treated by myomectomy (20). 
The patients that remain infertile despite myomectomy and the large numbers that have 
undergone hysterectomy because of large symptomatic leiomyoma belong to the group of 
leiomyoma-related uterine infertile patients that could be treated by UTx.  
 
Another cause of uterine factor infertility is intrauterine adhesions, where the endometrial 
cavity is totally or partly obliterated due to that opposing sides of the cavity is connected 
by adhesions. The prevalence of intrauterine adhesions is around 1.5% among fertile-aged 
females (21). Intrauterine infection is the most common cause of severe intrauterine 
adhesions (22). Other causes are surgical curettage at legal abortion or post partum (23). 
In general, intrauterine adhesions result in infertility in around 50% of women and if 
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In general, intrauterine adhesions result in infertility in around 50% of women and if 
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The less common unicornuate and uterus didelphys comprise around 20% of uterine 
malformations (26, 36). Disturbed development of one of the Müllerian ducts will result 
in the unicornuate uterus, with or without a contralateral rudimentary uterine horn. Such a 
rudimentary horn could be either communicating or non-communicating. It should be 
noted that there often is ipsilateral renal agenesis on the side of the rudimentary horn (28). 
In presence of a unicornuate uterus, there is higher obstetric risk and this anomaly is 
associated with increased risk of preterm labour (43%), spontaneous abortion (34%) and 
ectopic pregnancy (4%)) (37, 38). It is important to surgically remove a uterine 
rudimentary horn if that contains functional endometrium and this could be done by a 
laparoscopic hemihysterectomy (39).  
 
A total failure of fusion of the Müllerian ducts results in uterus didelphys, i.e. two 
separate uterine horns without a common cavity. The duplication of the vagina and the 
cervix may be partial or complete. The usual form is that of two separated uteri but with 
the endocervical channels fused at the distal end. The potential to establish a pregnancy in 
these two types of malformed uteri is decreased and in case of pregnancy around 30% 
will end in miscarriage and the total live birth rate is only around 50% (26). Surgery does 
not seem to improve the pregnancy potential of the unicornuate/dideplhys uterus (40). 
However, there exist reports of simultaneous pregnancies in each didelphic horn, with 
long intervals between deliveries (41) that would indicate origin in different ovulatory 
cycles. 
 
The most extensive type of Müllerian duct anomaly is uterine agenesis, which represents 
around 3% of all these congenital uterine malformations (26) and it is seen in around one 
in every 4500 females (42). Typically these women have a rudimentary solid bipartite 
uterus in combination with absence of the vagina above the hyminal ring. The syndrome 
is generally named the Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome or only the 
Rokitansky syndrome. Three subtypes of the Rokitansky syndrome exist. The typical 
subtype, which goes without extrauterine malformations, is present in around 50% and 
the atypical subtype, with associated malformations in the renal system, is present in 
around 20%. In the remaining 30% of the patients a severe form of Rokitansky syndrome 
exists with malformations also in the skeleton of the upper back and neck (43). The 
outcome of gestational surrogate pregnancies in Rokitansky patients as the genetic 
mothers (44) does not demonstrate any increased malformation risk in the offspring.  
 
 
Rejection  
Prevention of rejection, by using effective immunosuppression is a main focus of this 
thesis which is about UTx. Transplantation of any organ or tissue allograft stimulates an 
immune response in the host, directed against the donor tissues. The extent of this 
immune response to a graft may depend on the degree of genetic disparity between the 
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donor and the recipient. Clinically and depending on the onset of tissue destruction, 
rejection can be categorized into 3 groups: hyper acute, acute and chronic rejection.  
 
Hyperacute rejection 
Hyper acute rejection can be defined as very early graft destruction that appears within 
minutes to some hours after connecting the graft to the blood vessels. This type of 
rejection occurs in individuals with preformed antibodies against major allograft antigen.  
These preformed antibodies may be specific for ABO blood group antigen or they may be 
for allogeneic MHC molecules that have been developed during a prior exposure of the 
recipient to allogeneic cells due to for example blood transfusion, pregnancy or previous 
organ transplantation (45). In a UTx situation, the most common origin of this is likely to 
be previous transfusion, since the procedure would be restricted to previously infertile 
women and previous organ transplantation, this should exclude the patient from another 
major surgical trauma such as UTx. The preformed antibodies bind to the antigens in the 
vascular endothelium of the graft and activate the complement and clotting systems, 
thereby destroying the endothelial lining of the graft and this may lead to immediate 
thrombus formation (45).  
 
The morphologic spectrum resulting from hyperacute rejection has been described for 
renal and cardiac transplants in experimental rats and primates (46, 47) as an edematous, 
mottled, and cyanotic graft within minutes to hours of vascular anastomosis. Hyper acute 
rejection is not common in the clinical settings, because every individual is tested for 
blood type and for antibodies against the cell of potential donor. This test is known as 
cross-match. 
 
Acute rejection  
Acute rejection usually occurs within weeks to month of transplantation and is the major 
immunological risk for developing allograft dysfunction. This process is considered 
primarily a T-cell mediated process (cellular mechanisms) although humoral (antibody 
mediated) mechanisms also contribute. In this T cell-dependent pathway to rejection, 
donor alloantigens are processed by specialized cell known as antigen-presenting cells 
(APCs), which by activation of alloreactive recipient´s T-cell leads to damage of the 
graft.  
 
Patient with acute cellular rejection may be without clinical signs or symptoms but often 
present with sudden deterioration in allograft function.  Most of the immunosuppressive 
drugs that are currently used are designed to prevent acute allograft rejection by depleting 
the recipient´s T-cell. Evidence of acute rejection occurs in the majority after organ 
transplantation but it can be reversed with adjustment of immunosuppressive therapy. 
The immunological mechanisms involved in acute rejection are fairly well characterized.  
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This type of allograft rejection involves three consecutive steps. At first there is 
recognition of alloantigen by the recipient´s T-cells and this is followed by activation of T 
cells. Finally, these activated T cells attack and destruct the allograft. Antigens, antigen-
presenting cells (APC), and T-cells are the three major players involved in this process.  
 
Proteins encoded in the MHC are the major antigens that stimulate graft rejection. These 
MHC antigens may be MHC class I or class II. Class I MHC antigens are expressed on 
the surface of all nucleated cells. Class II MHC antigens are mainly expressed on the cell 
surfaces of B -lymphocytes, macrophages, and dendritic cells, which also are known as 
APCs. The main function of APCs is to present antigens to T-cells. In addition to this, the 
APCs also transport the antigens to lymphnodes where naive T cells are located, facilitate 
the binding of T cells, and provide stimulatory signals for T-cell activation.  
 
The activation of the recipient´s T-cells can occur by three distinct pathways of 
allorecognition: direct, indirect and semi-direct pathways. Direct allo-recognition is the 
interaction of T-cells of the recipients through the T-cell receptor (TCR) with the 
allogeneic MHC molecules presented by graft-derived APCs, and in particular by 
dendritic cell. When peptide derived from donor MHC antigens are processed and present 
by recipients APCs, this process is known as indirect pathways. Semi-direct allo-
recognition is the pathway wherein recipient APCs acquire donor MHC through cell-to-
cell contact, which activates a T-cell response in the recipient. 
 
When the MHC-antigen complex on APC is bound by receptors on the naïve T-cell, 
antigen-specific signals get delivered to the T-cell through the TCR-CD3. These signals 
are not sufficient to activate T cells. A second essential signal is costimulatory molecules 
that are engaged with their ligands on APCs. The interaction of CD28 on the T cell 
surface with its APC surface ligands, B7-1 or B7-2, is one of the major costimulatory 
pathways. Additional costimulatory molecules include the CD40 and its ligand CD40L 
(CD154). Once the T cells are activated, they become effector T-cells and mediate 
allograft rejection.   
 
Chronic rejection 
Chronic rejection occurs within month or years after transplantation and gradually causes 
a continuing weakening of graft function. Although there are differences in appearance of 
chronic rejection between organs, it is usually characterized by fibrosis of the graft and 
associated vasculature besides progressive deterioration of graft function. It is estimated 
that chronic rejection affects up to 50% of allografts after five years of transplantation 
(48). Thus, chronic rejection remains a serious obstacle in solid-organ transplantation.  
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Immunosuppression 
Immunosuppressive protocols in the clinical setting can be categorized as either 
induction/ maintenance therapies to prevent allograft rejection or short courses of 
intensive therapies, also known as rescue therapies, to suppress an acute episode of 
rejection. Different pharmacological agents that are used in organ transplantation and 
their mode of action are presented in Table 1. 
 
Induction therapy works by depleting the circulating T lymphocytes of the recipient, and 
will then delay the onset and severity of the first episode of acute rejection. The induction 
therapy currently used in solid organ transplantation usually consist of high dose of 
maintainance drugs (calcineurin inhibitors, corticosteroids) and also includes polyclonal 
antithymocyte  globulins (ATG), anti-interleukin-2 (IL-2) receptor monoclonal 
antibodies, such as daclizumab and basiliximab, Campath-1H (alemtuzumab), and anti-
CD3 monoclonal antibodies.. 
 
The maintenance therapy is typically designed as a tri-agent approach.  The most 
commonly used immunosuppressive combination is that of a calcineurin inhibitor 
(tacrolimus or cyclosporine) an antiproliferative agent, such as mycophenolate mofetil, 
and corticosteroids, such as prednisolone.  
 
Treatment or “rescue” therapy is provided during episodes of acute rejection and typically 
starts with corticosteroid boluses.  
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Table 1 Common immunosuppressive agents used in organ transplantation 
 
Drug Mode of action 
Induction  
Anti-thymocyte globulins Reduces number of effector T cells, and blocks their function 
IL-2 receptor antagonists 
(daclizumab, basiliximab) 
Targets IL-2 receptors on T cells and block their IL-2-dependent 
activation 
Maintenance  
Cyclosporine Inhibitor of T cell activation, binds to cyclophilin and this complex 
inhibits calcineurin phosphatase and thus inhibit IL-2 production 
and T-cell activation 
Tacrolimus 
 
Inhibitor of T cell activation, bind to FKBP12 to inhibit 
calcineurin phosphatase and thus inhibits IL-2 production and T-
cell activation 
Prednisone, prednisolone, 
methyl prednisolone 
Multiple anti-inflammatory and immunomodulatory effects, 
Inhibit the transcription and production of several pro-
inflammatory cytokines  
Inhibit macrophage activation 
Azathioprine Converts 6-mercaptopurine to block the de novo pathway of 
purine synthesis by formation of thio-inosinic acid 
 
Mycophenolate mofetil Blocks purine synthesis, inhibits proliferation of T and B-cells 
Sirolimus 
Everolimus 
Inhibits interleukin-2 driven T-cell proliferation 
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Aims of the study 
 
The general aim of this thesis was to develop an animal model for UTx in the rat and to 
use this to explore various issues on UTx.  
 
The specific aims were: 
1. To develop a model for heterotopic UTx with comparisons to a native uterus 
(Paper I) 
 
2. To further develop the vascular UTx model in the rat to enable spontaneous 
mating and to assess pregnancy outcome in a syngeneic model (Paper II) 
 
3. To establish whether tacrolimus, as a single immunosuppressive agent is able to 
prevent rejection in an allogeneic UTx model (Paper III) 
 
4. To investigate the feasibility of different sites for diagnosis of early rejection in an 
allogeneic UTx model in the rat (Paper IV) 
 
5. To determine if allogeneic UTx in the rat with immunosuppression is compatible 
with fertility (Paper V) 
 
6. To determine if offspring from an allogeneic UTx situation is of normal birth 
weight and demonstrate normal growth trajectory (Paper VI) 
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Materials and Methods 
The methods, animals and materials that have been used in the uterus transplantation 
(UTx) studies of this thesis are briefly described below. Detailed descriptions can be 
found in the “Materials and Methods” sections of individual papers. 
 
 
Animals and experimental groups 
Adult, virgin female rats that were used as uterus donors and recipients in all UTx studies 
weighed between 150 and 170g. Male Lewis (Paper II) or Sprague Dawley rats (Papers 
V, VI) of proven fertility were used for mating. Rats that were used in Paper I, II and III 
were purchased from Charles River, Sulzfelt, Germany. Rats that were used in Paper IV, 
V and VI were from Harlan Laboratories, Horst, Netherlands.  
 
After arrival from the breeder, all the animals were housed in the animal facility of 
Experimental Biomedicine of the University of Gothenburg. The housing conditions were 
22ºC with controlled light/dark cycles of 12h: 12h and with free access to pelleted food 
and water. All experimental protocols were approved by the Animal Ethics Committee in 
Gothenburg, Sweden.  
 
In Paper I and II, transplantation was performed between genetically identical animals of 
the same inbred strain (syngeneic transplantation). In Paper III –VI, UTx was done in 
allogeneic setting, which was transplantation between different inbred strains of rats. A 
summary of all rat strains used and the type of UTx is given in Table 2. 
 
Control groups were included in several studies. Groups with sham-surgery were included 
in Paper II, III, V, and VI. Groups with administration of immunosuppression but not 
undergoing UTx were included in Paper III, V and VI. The native uterus was used as 
control tissue in Paper I and IV.   
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Table 2 Rat strains and type of UTx in experiments of Paper I-VI  
Paper Donor  
 
Recipient 
 
Transplantation model  
 I Lewis Lewis syngeneic, heterotopic 
II Lewis Lewis syngeneic, orthotopic  
III Brown Norway Lewis allogeneic, orthotopic  
 IV Lewis PVG allogeneic, orthotopic  
 V Dark Agouti Lewis allogeneic, orthotopic  
 VI Lewis PVG allogeneic, orthotopic  
 
 
The experiments involving UTx were performed utilizing four different combination 
inbred rat strains: Lewis (RT1I), Brown-Norway (RT1n), Dark Agouti (DA, RT-1a) and 
PVG (Piebald Virol Glaxo, RT1c). All of these strains have been widely used in 
transplantation-related research for many years. 
 
Lewis (RT1I) rat is an inbred stain of laboratory rat, developed from Wistar stock in the 
early 1950s. This strain was used in experiments of Papers I and II, since these rats show 
high fertility and have pelvic vascular anatomy that is favourable for UTx surgery.  
 
The Brown-Norway (RT1n) is also an inbred stain of laboratory rat, but the pelvic 
vascular anatomy may differ between animals of the same litters. Brown-Norway (RT1n) 
to Lewis is a commonly used rat strain combination in experimental multivisceral and 
intestinal transplantation (49). This rat strain combination differs at both major and minor 
histocompatibility loci (50) and has been found to produce complete allograft rejection 
after experimental lung (51) or intestinal (52) transplantation, when  immunosuppression 
is not given. This combination of rats was used in the study III. 
 
In Paper V, the combination of  Dark Agouti (DA, RT-1a ) as uterus donors and Lewis 
(LEW) was used, which is also a fully allogeneic model (53), with fulminant  transplant 
rejection if immunosuppression is not used (53, 54). 
 
The Lewis to PVG combination was used in tests of fertility (Paper VI) since this 
allogeneic combination may induce a slightly weaker immune response as shown in 
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control tissue in Paper I and IV.   
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Table 2 Rat strains and type of UTx in experiments of Paper I-VI  
Paper Donor  
 
Recipient 
 
Transplantation model  
 I Lewis Lewis syngeneic, heterotopic 
II Lewis Lewis syngeneic, orthotopic  
III Brown Norway Lewis allogeneic, orthotopic  
 IV Lewis PVG allogeneic, orthotopic  
 V Dark Agouti Lewis allogeneic, orthotopic  
 VI Lewis PVG allogeneic, orthotopic  
 
 
The experiments involving UTx were performed utilizing four different combination 
inbred rat strains: Lewis (RT1I), Brown-Norway (RT1n), Dark Agouti (DA, RT-1a) and 
PVG (Piebald Virol Glaxo, RT1c). All of these strains have been widely used in 
transplantation-related research for many years. 
 
Lewis (RT1I) rat is an inbred stain of laboratory rat, developed from Wistar stock in the 
early 1950s. This strain was used in experiments of Papers I and II, since these rats show 
high fertility and have pelvic vascular anatomy that is favourable for UTx surgery.  
 
The Brown-Norway (RT1n) is also an inbred stain of laboratory rat, but the pelvic 
vascular anatomy may differ between animals of the same litters. Brown-Norway (RT1n) 
to Lewis is a commonly used rat strain combination in experimental multivisceral and 
intestinal transplantation (49). This rat strain combination differs at both major and minor 
histocompatibility loci (50) and has been found to produce complete allograft rejection 
after experimental lung (51) or intestinal (52) transplantation, when  immunosuppression 
is not given. This combination of rats was used in the study III. 
 
In Paper V, the combination of  Dark Agouti (DA, RT-1a ) as uterus donors and Lewis 
(LEW) was used, which is also a fully allogeneic model (53), with fulminant  transplant 
rejection if immunosuppression is not used (53, 54). 
 
The Lewis to PVG combination was used in tests of fertility (Paper VI) since this 
allogeneic combination may induce a slightly weaker immune response as shown in 
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experimental intestinal transplantation (55). Since the most likely event in future human 
UTx would be a reasonable but not full MHC match, this combination was used in Paper 
VI.  However, preparatory studies with UTx and no immunosuppression given showed 
complete rejection with this strain combination.   
 
 
Anaesthesia  
The animals were anaesthetized using isoflurane (5% isoflurane was used for induction 
and 1-1.5% isoflurane was used for maintenance of anesthesia) in a mixture of air 
(600ml/min for induction, 300 ml/min for maintenance) and oxygen (600 ml/min for 
induction, 300 ml/min for maintenance). The operations were performed under an 
operating microscope (Leica M651; Leica Microsystems, Wetzlar, Germany). 
Throughout the surgery the body temperature was maintained at 37o C, by keeping the 
animal on a warm heating pad. 
 
 
Surgery of uterus retrieval  
The procurement of the uterine graft was basically the same in Papers I-VI and the 
procedure is described in more detail in the individual papers. 
 
In brief, after the rat was anesthetized, heparin (1000 IU/kg body weight) was injected sc 
and a midline longitudinal abdominal incision (from the sternum to pubic symphysis) was 
performed to open the abdominal cavity. A graft containing the right uterine horn, the 
common uterine cavity with the cervix and the upper part of the vagina and a vascular 
pedicle comprising the right uterine vessels with the ipsilateral internal iliac vessels up to 
and including the entire common iliac vessel was isolated. 
 
The graft was then flushed in situ with 1-2 ml of cold (4°C) Perfadex  preservation 
solution (Vitrolife AB, Mölndal, Sweden), supplemented with xylocaine (0.4 mg/mL) and 
heparin (50 IU/mL) until the graft was uniformly pale and the venous effluent was clear. 
The harvested graft was then kept in Perfadex solution (4°C) while the recipient was 
prepared for UTx. In Paper I, Ringer Acetate supplemented with xylocaine and heparin 
was used as both flushing and preservation solution. All experiments involving the donor 
animal was ended by the donor rat being euthanized by cardiac puncture.  
 
 
Surgery of the uterus recipients 
Heterotopic UTx, with transplantation of the uterus to an unphysiological position, was 
performed in Paper I and orthotopic UTx, with transplantation to the normal position, was 
performed in Paper II-VI. 
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Orthotopic uterus transplantation 
 
In the recipient, a hysterectomy was performed with (Paper II, V and VI) or without 
(Paper III and IV) preserving a small portion (1cm) of the upper part of the right uterine 
horn (Fig. 1). This procedure was initiated after injecting low molecular weight heparin 
(dalteparin; 500UI/kg bodyweight) sc, to prevent thrombosis formation during further 
surgery.  
 
For vascular anastomosis, the right common iliac vessels were dissected free and 
separated from each other for the whole length from the aortic bifurcation until the 
branching of the internal and external vessels. The grafted uterus was brought from the 
backtable into its position within the abdomen of the recipient, where the uterus was kept 
cold during the period of anastomosis surgery by intermittent dripping of cold (4°C) 
physiological saline. Vascular clamps were place over the artery separately and a very 
small portion of the arterial wall was removed to make a hole on the anterior wall of the 
right common iliac artery. This place would accommodate anastomosis with the end of 
common iliac artery of the graft. An end to side anastomosis was performed between the 
common iliac artery of the graft and recipient´s right common iliac artery, using 
semicontinuous (Paper II, III, and V) or interrupted (Paper IV and VI) 10-0 nylon suture 
(Fig. 1). This was followed by a similar procedure for the venous anastomosis using an 
end-to-side fashion with 10-0 (Paper II, III, V) or 11-0 nylon (Paper IV and VI) 
hemicontinous suture. 
 
In Paper II, V and VI fertility after spontaneous mating was an endpoint. In these 
experiments the tip of the uterine horn of the graft was anastomosed with the native 
uterine tip that was kept at the end of hysterectomy (Fig. 1). In Paper III and IV, the tip of 
the uterine horn of the graft was fixed with a single 7-0 nylon suture to the tissue 
surrounding the clip that had been placed during hysterectomy, in a position that was 
between the tip of right uterine horn and the right oviduct of the recipient.  
 
In all these experiment the vagina of the graft was anastomosed to the vaginal vault with 
interrupted resorbable 6-0 polyglactin sutures.  
 
The abdomen was subsequently closed in two layers using a continuous 6-0 polyglactin 
suture in two layers. Three ml of 4% icodextrin solution (Adept ®; Baxter, Deerfield, IL, 
USA) was placed inside the abdominal cavity before closure to prevent post-operative 
intra-abdominal adhesions (56) . 
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Heterotopic uterus transplantation 
 
In Paper I, heterotopic UTx was done and the native uterus of the rat was kept intact (Fig. 
1). The vascular anastomosis was prepared between the common iliac vessels of the graft 
and recipient’s aorta and vena cava, using semicontinuous 10-0 nylon suture. The vaginal 
end of the graft was exteriorized through the abdominal wall to create an abdominal 
stoma. The tip of the uterine horn remained free in the abdominal cavity. The abdomen 
was closed as described above. 
 
 
Sham surgery  
Sham-surgery was used in Paper II, III, V and VI to create appropriate control groups. 
Sham-operated animals underwent laparotomy with removal of left uterine horn to 
achieve an animal, which was anatomically similar as after UTx. Via midline laparotomy 
a titanium clip was placed between the left oviduct and the tip of the horn and another 
clip was placed between the proximal edge of the left uterine horn and the common 
uterine cavity. The portion of the uterus between the two clips was removed and the 
abdomen was closed. 
 
   
 
Figure 1. Schematic drawings of UTx procedure. Left panel; Hysterectomy in orthotopic uterus 
transplantation procedure. Middle panel; Orthotopic placement of an uterus. Right panel; 
Heterotopic placement of an uterus. The grafted uterus is shown in gray. 
 
Immunosuppression  
In Paper III, V and VI immunosuppression by tacrolimus was used to prevent rejection of 
the allogeneic uterine grafts. The rats that received immunosuppression were given 
tacrolimus sc via implanted Alzet 2ML4 or 2004 model miniosmotic pumps (Alzet, 
Durec, Cupertino, CA, USA) at a dose of 0.5 or 0.4 or 0.2 mg/kg/day based on the study 
protocol. The pump was filled with a solution of tacrolimus (tacrolimus diluted in 0.9% 
NaCl), which was prepared individually for each animal in relation to the weight of the 
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animal and then primed in 0.9% NaCl solution at 37°C for 24 h according to the 
manufacturer's instructions. Then, at the end of surgery in the UTx animals or as a single 
procedure in the control groups, the pump was implanted in the sc. space on the back of 
the animal. This procedure was performed under isoflurane anesthesia and the wound was 
closed with Micelle clips (Kent Scientific, Torrington, CT, USA). 
 
Tail blood samples were collected throughout the experimental period and blood 
concentrations of tacrolimus were measured by a chemiluminescent immunoassay 
(ARCHITECT®, Abbott Scandinavia AB, Solna, Sweden).  
 
 
Reproductive performance after uterus transplantation  
In Paper II, V and VI, the endpoinf of these experiments was pregnancy. After a recovery 
and healing period of six to eight weeks after surgery (UTx or sham-surgery), the female 
rats were placed with males of proven fertility. After that, the female rats were examined 
every morning for 4 days for an indication of mating. Those with presence of vaginal plug 
were considered to be pregnant (defined as Day 0 of pregnancy).  Based on the study 
protocol, delivery of the litters or the rat was allowed to go vaginally (Paper II) or 
planned cesarean section was done on either pregnancy Day 17 (Paper V) or Day 22 
(Paper VI). The litter size and the number of living pups were noted. At the end of the 
cesarean section or delivery, all animals were euthanized and their uteri were examined 
for signs of partially resorbed pregnancies and uterine biopsy was collected.  
 
The pups were then placed with foster mothers.  Sprague-Dawley females delivered per 
vaginally 1 or 2 day prior to the day of the cesarean section of experimental animals were 
used as foster mothers. The pups were then followed by weekly weight measurements 
from Day 1. The follow-up period ranged from 6 weeks (Paper II) to 19 weeks (100 days, 
Paper VI) according to the study protocol. 
 
 
Graft harvesting 
Depending on the study protocol (Paper I, III and IV) the uterine tissues were collected on 
the pre-defined post-operative day. Each harvested uterine graft was cut into three 
portions. Portions for histological staining and immunohistochemistry were fixed in 4% 
normal buffered formalin solution. Sample portions for RNA isolation were placed into 
RNA later and then were stored at -20°C. 
 
 
Histology 
Detailed histological analysis of uterine grafts was performed in Paper I, III and IV. 
Tissue biopsies from the grafted uteri were collected and submerged into buffered 
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formaldehyde (4%). This was followed by dehydration and the specimen was later 
embedded in paraffin and sectioned (4 µm thick). The sections were then stained with 
eosin and hematoxylin and analyzed under light microscopy.  
 
 
Immunohistochemistry 
Immunohistochemistry was used in Paper III to detect and quantitate CD3, CD4 and CD8 
positive lymphocytes. Rabbit polyclonal anti-CD3 (Abcam, Cambridge, UK), mouse 
monoclonal anti-CD4, (Serotec, Düsseldorf, Germany) and mouse monoclonal anti-CD8 
(Serotec) were used as primary antibodies.  
 
In the protocol, deparaffinized slides were rehydrated through descending ethanol 
concentration and then boiled in a pressure cooker with 0.01 M citrate buffer with 0.05% 
Tween 20 (pH 6.0) for 20 min or treated with pronase for antigen retrieval. Following 
washing in Tris-buffered saline (TBS), the sections were incubated with Biocare's 
Background Sniper (Biocare, Concord, CA, USA) for 10 min at room temperature to 
block non-specific staining.  Primary antibodies against the T-lymphocyte specific 
antigens CD3, CD4 and CD8 were subsequently added and kept overnight at 4°C. After 
washing with TBS for 15 min, MACH 3 Mouse AP-Polymer detection kit (Biocare) was 
applied to the sections according to the manufacturer´s instructions. Slides were rinsed in 
TBS and then incubated with Vulcan Fast Red (Biocare). Finally the sections were 
counterstained with hematoxylin.  
 
The numbers of positively stained cells were counted within a grid (10 × 10 squares, 
0.125 mm2 in ×40 objective and ×10 eyepieces) by two independent observers (blinded 
fashion). In each section, five randomly chosen areas each of the endometrium and the 
myometrium were counted and the average values for each section were used as 
individual data points.  
 
 
Quantification of mRNA 
In Paper III, messenger ribonucleic acid (mRNA) levels of certain genes were quantified. 
At first, total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA, USA) from the 
uterine tissue sample according to the manufacturer´s protocol. The integrity of the 
extracted mRNA was then assessed using the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Kista, Sweden).  
 
Extracted mRNA was then reversed transcribed into complementary deoxyribonucleic 
acid (cDNA) using 2 µg total RNA with 0.5 µg random primer (Promega, Madison, WI, 
USA), 0.5 mM deoxy-NTP, 20 U RNAsine, RT-buffer and 200U Moloney murine 
leukaemia virus reverse transcriptase (Promega). 
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Real-time quantitative PCR (rtPCR) in an ABI Prism 7000 Sequence Detector system 
(Applied Biosystems, Foster City, CA, USA) was performed to evaluate the mRNA 
expression. Commercially available Taqman MGB probes (Applied Biosystems) were 
used for the target genes. Each amplification reaction consisted of 20 ng cDNA, 1x probe-
mix and 1x TaqMan Universal PCR mastermix (Applied Biosystems) to a final volume of 
25 µl. After control of amplification efficiency of the targets genes and the control genes, 
the relative expressions of mRNA were calculated using the comparative CT method (57). 
Expression of the target gene mRNA were normalized to the expression of the control (β-
actin).The mRNAs for interleukin (IL)-1α, nuclear factor (NF)-κB, interferon-inducible 
protein (IP) 10, leukemia inhibitory factor (LIF), galectin-1, CD200 and IL-15 were 
studied in Paper III.  
 
 
Statistics  
In Paper I, IV and V, no statistical analysis was done. Concerning Paper I, data related to 
surgical time and survival is presented as mean ± standard deviations of mean and data 
related to quantification of neutrophils presented as medians with 10-90% ranges. 
Concerning Paper IV and V, data related to surgery, cold and warm ischemic times are 
presented as medians, ranges, and pregnancy rate is presented as percentages (%). The 
non-parameteric Wilcoxon signed-ranks test with presentation of data as medians and 
ranges was used to compare durations of surgery and cold ischemia (Paper II), as a post- 
test after Kruskal Wallis test for data of Paper III. For multiple comparisons the 
nonparametric Kruskal Wallis test (Paper III, VI) or the parametric ANOVA test (Paper 
VI) were used.  
 
Mating, pregnancy and conception frequency between transplanted and control animals of 
Paper II were compared using X2 test. For all comparison, a p-value of <0.05 was 
considered to be statistically significant.  
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Results and Comments 
Paper I 
 
Background 
Intense research in the field of UTx has been ongoing since around year 2000. This 
scientific activity started after the first human UTx case was performed that year and later 
published in year 2002 (58). The first animal UTx-model, which was developed and also 
properly explored, was the mouse model. The research group that I belong to showed for 
the first time pregnancies after syngeneic mouse UTx (59) and later also normal offspring 
in this model (60). Other groups around the world investigated large animal models such 
as the pig (6, 61) and the sheep model (62) in scientific efforts to move the field towards 
human UTx.  
 
A drawback with large animals is of course the large costs of the animals and the 
complicated and personal-intense animal care as well as that there is a shortage of inbred 
strains of large experimental animal, which can be used for syngeneic transplantation 
experiments. These syngeneic UTx models are of great use since there is no rejection, and 
the outcome can be interpreted as a result mostly secondary to surgery or ischemia 
reperfusion events.  
 
In the field of transplantation, the rodent models of the rat and the mouse are most 
frequently used and are in many ways suitable first line transplantation research model, 
due to the comparative easy handling. Moreover, preoperative and post-operative care of 
small animals is easier than large animals. The rat may be a more suitable model than the 
mouse because of several reasons. This assumption is based on that microsurgery in 
mouse model is very complicated (59) (63) due to small size of the blood vessels and 
pelvic organs, which is related to the body weight of the mouse being around about 25 g. 
Furthermore, the relative doses of immunosuppression that is needed to prevent rejection 
of allografts in rat are in agreement with that of the human (64, 65). Thus, in attempts to 
prevent rejection of allografted mouse uteri it was found that very high levels of 
cyclosporine had to be used and that the results was more that the rejection was delayed 
somewhat, rather than prevention of rejection (66). Similarly, cardiac allografts in a 
mouse model were found to be rejected when CsA trough levels reached 1000 ng/ml, in 
contrast to the rat model in which only one-tenth of that dose of CsA prevented heart 
rejection (67).  
 
In the present study the rat was explored for the first time as a model for UTx. The 
methodology was based partly on the technique from the previously published mouse 
model (60) but modifications were performed to adjust for the larger vascular anatomy of 
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the rat. In the first set of experiments inbred Lewis rats were used both as donors and 
recipients, with the weight being around 5-6-fold larger than mouse model.  
 
 
Results 
The donor operation was developed to isolate the right uterine horn and the common 
uterine body and the cervix with a small vaginal rim. The left uterine horn was excised in 
a way that only blood vessels from one side needed to be included in the preparation. The 
hypothesis was that the ipsilateral uterine blood vessels would be connected to the 
remaining uterine horn but with the descending parts of the uterine artery/vein being 
sufficient for perfusion also of the common uterine body, the cervix and the upper part of 
the vagina. 
 
In the recipient, the subrenal aorta and vena cava were prepared for anastomosis. The 
common iliac artery and vein of the graft was then sutured end-to-side to the subrenal 
aorta and subrenal vena cava. The vaginal rim of the graft was exteriorized through a 
stoma, which was created on the right side of the laparotomy scar. 
 
Two previously untrained microsurgeons were compared. Concerning the factor surviving 
animals, the rate was around 50-70% in the first animal but increased up to 100% in 
animals after number 30. The number of viable transplants in surviving animals was fairly 
constant and similar between the two microsurgeons with around 80% surviving grafts. 
Naturally the duration of surgery in both the donor rat and the recipient rat decreased with 
time, so that at the end of the experimental the total surgical time for the recipient was 
about 160 +15 min and donor surgery took 70 + 20 min. 
 
Concerning both investigators, the surgery of the recipient animal, including both 
dissection of the large blood vessels, as well as anastomosis of the vasculature and 
exteriorization of the distal end of the graft through the abdominal wall, was substantially 
longer than the recovery surgery of the donor animal. Both morphology and histology of 
the transplants carries out shortly after transplantation showed that the grafts were 
swollen and somewhat darker in colour than the native uterus. Moreover, a small 
accumulation of inflammatory cells was found in the uterine tissue at this immediate post-
transplantation period. On day 21 after surgery, both the gross morphology and the 
histology were similar to that of the native uterus. 
 
 
Comments 
This study represents the first detailed study on a rat model for UTx. One important 
aspect is that the surgery in this rat UTx model seemed to be manageable also for 
previously unskilled surgeons. Both surgeons of the present study did not have any 
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Results and Comments 
Paper I 
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previous microsurgical skills or any general surgical training. As expected, there was a 
typical learning curve, but the survival of the animals was almost 100% already after 30 
animals. It should be noted that the graft survival was fairly constant and concerning one 
of the surgeons, it was already high at rat 1-10 and decreased from 80% to 40% in rat 21-
30, to show an increase after that. This biphasic pattern is not typical for any surgical 
learning curve. It could reflect that the surgeon at this initial stage had overconfidence 
with the surgery, but with experience awareness of several surgical obstacles may have 
affected the results. Another explanation could be that the effort to speed up surgery 
negatively affected the outcome. 
 
The other investigator showed more steady increase in graft survival. In the last cohort of 
animals, when both surgeons had graft survival of more than 70%, some animals were 
investigated on postoperative day day 1, 7 and 21. 
 
The investigation of the uterine graft involved gross morphology, histology and estimated 
the number of infiltrating neutrophils. The fact that the uterine transplants were slightly 
darker and appeared somewhat more swollen than the native uterus at day 1, probably 
reflect the tissue response to the surgical trauma and the ischemia of the uterus. This 
would be expected also in a normal surgical situation, where only gentle manipulation of 
the uterus is performed. Concerning the ovary, it has been shown that even if the ovary is 
only slightly touched during surgery, there will be focal loss of surface epithelium (68). 
Similar mechanisms are most likely also operative concerning the serosal surface of the 
uterus.  
 
At day 7 and 21 of surgery, the gross morphology of the transplanted uterus was similar 
to the native uteri. Histology showed small signs of inflammation in the day 1 transplants 
but the difference between the grafts and the native uteri disappeared during the follow up 
time. The number of neutrophils was in the same range in the native and in the graft uteri 
during the entire study period. Thus, no firm conclusion could be done whether any minor 
inflammation persisted in the transplanted graft. 
 
During the last decade several animal models for UTx research have been developed.  
 
According to the large animal models the rat will of course have the drawback of its small 
size and that this would necessitate surgical skills by the investigator. Importantly in the 
present study we could show that two previously inexperienced microsurgeons with no 
previous training in clinical surgery were able to master this method after a relatively 
short learning period. It should be noted though that the grafts survival did never reach 
above 80% apart from early success of one of the investigators. It may well be that the 
graft survival would reach even higher with longer learning. 
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However, it is my experience after doing more than 250 surgeries in a similar animal 
model that there will always be some losses of organs and that this is usually due to 
formation of thrombosis. Stenosis on the venous side or inadequate handling of graft 
during surgery is the most likely reason of thrombosis. Thus, the venous anastomotic size 
should also be made as wide as possible without any twist. Furthermore, the length of the 
graft artery and vein should be similar. One more important point to reduce graft loss is 
that the graft should be covered with a wet gauge and cold saline should be poured 
intermittently over the graft during the period of anastomosis to keep the graft cold. 
Minimum manipulation of the graft as well as graft vasculature is also crucial to reduced 
graft thrombosis. 
 
When removing blood from the graft uterus, aggressive flushing should be avoided. 
Moreover during recipient preparation, while the graft is preserved in cold preservation 
solution and it should be immersed fully during the entire period. 
It should also be stated that, during the study period of this thesis a significant number of 
animals died between post-operative day 1 and 2. Bleeding from the anastomosis site was 
the main reason of death of these animals. Bleeding from venous anastomosis can be 
minimize by meticulous provition of hemostasis matrix but bleeding from the arterial 
anastomotis can rarely be stopped using hemostasis matrix.  Moreover it causes extensive 
adhesion. Thus, I favour to use an extra suture using 11-0 nylon at the site of bleeding in 
both arterial and venous anastomosis rather than using meticulous hemostasis. 
 
In clinical transplantation there will also be a very small but significant loss of grafts due 
to surgical reasons. However the difference is that even if thrombosis occurs early on in 
post transplantation this can usually be corrected by a re-surgery within a short time. 
 
 In the present study we had none who was observing the post transplantation blood flow 
in the graft and could not do intervention surgery. Both gross morphology and light 
microscopy were used to evaluate the graft function. In this case, naturally light 
microscopy is a more sensitive method but the results indicated that the findings go in 
parallel so that when a slight inflammation was present in the tissue this was paralleled by 
also slight gross morphology signs.  
 
Several histological methods can be used to assess the grade of inflammation. In the 
present study, the number of neutrophils was used as a measure to assess the grade of 
inflammation. It is known that extensive inflammation with primarily influx of 
neutrophils occur after ischemia re-perfusion injury to most transplanted organs (69, 70) 
injury and this is the reason why this parameter was assessed. We have previously shown 
that the human uterus is comparable resistant to cold ischemia (71), since spontaneous 
and prostaglandin-induced myometrial contractions were seen after 24h of cold ischemic 
preservation. In a recently accepted study on warm ischemia tolerance of the transplanted 
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rat uterus we also show the uterus is fairly resistant to warm ischemia, with warm 
ischemic times of 3-4 h (72).  
 
A small number of the assessment of uteri on day 7 and day 21 had swollen uterine 
lumina with obstructive cervical opening. This is probably due to that the surgery of the 
stoma was not optimal in that sense that the opening was constricted. This of course needs 
further development in the future experiments on a heterotopic UTx model.  
 
 
Paper II 
 
Background 
The reason to carry out research and development concerning UTx is of course to perform 
this procedure as one way to find a treatment for women with absolute uterine factor 
infertility. The women with absolute uterine factor infertility, either lack uterus or have a 
non- functioning uterus, which is unable to implant an embryo or is not functional to 
nourish the growth of an embryo to a pregnancy length, which allows for delivery of a 
healthy baby.  . Other future alternatives apart from UTx, although today relatively 
uncertain, for absolute uterine factor treatment could be development of a bioengineered 
uterus, created by stem cells on a synthetic matrix, as performed concerning the human 
trachea (73), or to use decellularized tissue from multi-organ donors. This latter 
technique, with decellularised tissue recomposed with autologous stemcells, was lately 
successfully carried out to form a vein graft, which was then successfully transplanted 
into a 10 year old girl who was suffering from extrahepatic portal vein obstruction (74). 
Both these future alternatives would mean that the patient would not need any 
immunosuppression, since the stem cells would be autologous. 
 
Another future possibility, which has been discussed concerning the uterus, is that the 
whole pregnancy can be carried out outside the body, in an artificial incubator which 
would mimic the in vivo situation inside the uterus (75).This so called ectogenesis 
approach has been partly successful in goats, where fetuses were removed from their 
dams and then supported with an artificial placenta and uterus for 3 weeks (76).  
 
The functionality of a transplanted uterus can of course be examined by different means. 
In the short time-course, assessment of functionality would incorporate normal and viable 
histology of the specimen. After that, a normal cyclic pattern of the uterus would indicate 
that the uterus reacts to the hormonal changes during the cycle, and that it most likely 
would carry an endometrium that is prepared for implantation. However, since the 
ultimate goal of UTx is to treat infertility of the patient group with absolute uterine factor 
infertility, the definitive functional test is of course examination whether a transplanted 
uterus can carry a pregnancy to term and to deliver live offspring. 
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In a clinical human situation, allogeneic uterus transplantation would be used, rather than 
the syngeneic transplantation setting, which had been used previously in the mouse (59, 
60) and also in the rat in the present paper. Occurrence of pregnancy after allogeneic UTx 
may be prevented both by factors due to the surgical trauma of transplantation, the new 
blood flow of the uterus or possibly by immunosuppression to prevent rejection. It would 
thus be very difficult to interpret the data on tests of pregnancy potential in an allogeneic 
setting since this involves many unknown factors. The present study was developed as an 
initial step towards allogeneic UTx in the rat. Thus, syngeneic UTx was used with fertility 
assessment after spontaneous mating.  
 
 
Results 
The transplantation surgery was modified from that of Paper I so that the anastomosis of 
the vasculature was performed using the right-sided common iliac vessels of both of the 
graft and of the recipient. The anastomosis was carried out end-to-side using 10-0 sutures 
and all of the surgery was performed under a steromicroscope.  
 
In order to allow for pregnancy after spontaneous mating, the previous rat UTx method 
(Paper I) was also modified apart from the vascular anastomosis, so that the uterus was 
connected to the vagina and that undisturbed transport of sperms up to the oviductal-
uterus junction would still be possible. Thus, instead of having the previously heterotopic 
position of uterus, the recipient was hysterectomized but leaving both ovaries intact and 
also a very short tip of the native uterine horns. The graft (right uterine horn, common 
uterine cavity, cervix with vaginal rim) was placed in an orthotopic position with 
anastomosis of the tip of the right horn of the uterus graft with the minute tip of the right 
uterine horn of the native uterus. The vaginal tissue of the graft was also sutured end-to-
end to the native uterus of the recipient. Control animals also underwent surgery so that 
the left uterine horn was surgically excised in the same manner as it was done on the 
uterus to be transplanted, and in that way both experimental groups contained uteri with 
only one horn.  
 
The total success rate was 70%. Some animals did not survive the surgery due to bleeding 
or other reasons and furthermore a small number of animals did not have a satisfactory 
graft at second-look laparotomy, which was done in all cases 2 weeks after surgery. The 
cold ischemic time was around 2 h and the surgery time of the recipient was somewhat 
longer than 3 h. This surgical duration was considerably higher than the surgical time of 
around 40 minutes of the sham group.  
 
The 19 animals of the uterus transplantation group were compared with 19 animals of the 
sham group. Out of the 19 transplanted animals, 17 mated during the first cycle and 11 
became pregnant. The pups per pregnancy were about 3 in each group. The number of 
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resorbed pregnancies was higher in the uterus transplantation group. The weight 
trajectory for the pups born from the UTx rats was similar to the pups of control rats and 
these offspring were normal up to adult age. 
 
 
Comments 
This study represents the first published study on pregnancy in and live offspring from a 
truly transplanted uterus as a result of spontaneous mating. My research group has 
previously shown live offspring after autologous UTx in the sheep (77), but those results 
are not comparable to these since in the sheep experiments of the sheep the uterus was not 
moved between different individuals. It should also be mentioned that pregnancies have 
never been reported in a rat UTx model prior to this study.  
 
The choice of animal model for this study was based on that several investigators in the 
group had difficulties in obtaining success with the heterotopic UTx model in the mouse, 
as was initially used by the group (59). In the mouse, also orthotopic UTx was tested but 
with no pregnancies occurring after embryo transfer (Randa R Akouri, personal 
communication), which is in contrast to the heterotopic UTx mouse model with 
reasonable pregnancy rate (59, 60). 
 
The advantages of an orthotopic UTx model, as developed in the present study, is 
naturally that the uterus is in its usual anatomical location, and this may be important for 
its cyclic physiological changes but also to allow for expansion at pregnancy.  
 
The results of the present study show a reasonable pregnancy rate after orthotopic UTx, 
but there are several factors apart from the UTx that is not controlled for and that can 
affect the results. Thus, it may be that the extended surgical time of the UTx group, as 
compared to the control group, could have affected the ovarian function so that less 
numbers of oocytes would be released at ovulation. 
 
Concerning the end result of the inner reproductive tract after UTx, both the vaginal-
vaginal anastomosis and the utero-utero anastomosis may negatively influence the 
transport of sperms and embryos. It may also be that the blood flow of the oviduct is 
impaired after UTx, since the blood flow coming from the uterus would cease due to the 
surgical procedure.  
 
Even though the pregnancy rate of the experimental group was comparable to that of the 
control group, only few live births were accomplished from the experimental group. One 
can speculate that this was secondary to denervation of the uterus at transplantation and 
that this would affect the mechanisms of labour. Another explanation is that there was 
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some constriction in the vaginal anastomosis, although sutured with resorbable sutures, 
and that this would prolong the labour and thereby lead to fetal asphyxia. 
Of note is that the vascular anastomoses were accomplished by nylon sutures, which do 
not show any resorption in vivo. Thus, this would not allow for any expansion of lumen 
at the anastomosis site lumen during pregnancy, when the uterine blood flow is 
considerably increased. 
 
 
Paper III  
 
Background 
The magnitudes of the immune response and rejection vary with the type of tissue or 
organ that is transplanted. It is well described in transplantation surgery that the 
transplanted liver does usually not require heavy immunosuppression and some of these 
transplanted patients can be taken off completely from immunosuppressive therapy some 
years after transplantation. Thus, weaning of liver transplant recipients from their 
immunosuppressive drugs is widely practiced and several reports on liver recipients have 
shown that a liver allograft can maintain normal function without immunosuppression. 
Although drug withdrawals in these studies were associated with rejection in some 
recipients, the majority of these episodes of rejection was mild or was easily resolved (78-
80). In contrast, vascularized composite allografts, such as the hand and face, as well as 
intestinal transplants, usually require high doses of immunosuppression and also 
combinations of several drugs to avoid full rejection. This is thought to be due to that 
these tissues/organs contain large population of immunologic active cells such as the 
Langerhans cells of the skin and lymphoid tissue within the intestine. 
  
There exist only few studies concerning what immunosuppression to use after UTx in an 
allogeneic setting. In initial experiments from the early 1970s with the uterus transplanted 
by an avascular approach in the dog (81), the uterus was wrapped inside the omentum and 
the blood flow was re-established by neoangiogenesis. Azathioprine and corticosteroids 
were used as immunosuppressants but patchy necrosis was seen within one week and the 
allo-transplants later became fully necrotic.  
 
During the early 1980s, the first calcineurin inhibitor was introduced as a potent 
immunosuppressive agent. This first calcineurin inhibitor was cyclosporine A, which is a 
substance that was purified from either of two different fungi. Its main action is to prevent 
synthesis of interleukin (IL)-2 and thereby to inhibit activation and proliferation of mature 
T-cells, both of the CD4 and CD8 lineages. When cyclosporine was introduced in the 
clinic, it resulted in considerable improvement in the success rates concerning graft 
survival and the calcineurin inhibitors are today the mainstay in the immunosuppression. 
 
32 
 
resorbed pregnancies was higher in the uterus transplantation group. The weight 
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Comments 
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some constriction in the vaginal anastomosis, although sutured with resorbable sutures, 
and that this would prolong the labour and thereby lead to fetal asphyxia. 
Of note is that the vascular anastomoses were accomplished by nylon sutures, which do 
not show any resorption in vivo. Thus, this would not allow for any expansion of lumen 
at the anastomosis site lumen during pregnancy, when the uterine blood flow is 
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Paper III  
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Cyclosporine was used as an immunosuppressant in a rabbit model of non-vascular UTx, 
where the uterus was transplanted into the broad ligament (82). The drug was given by im 
administration at 15 mg/kg daily for two weeks and then the dose was tapered to 5 mg/kg 
day. The blood concentrations were not specified. This allogeneic transplantation was 
carried out in six animals, of which three rabbits developed peritonitis and pelvic 
abscesses. Three uterine grafts showed well-preserved endometrium and myometrium and 
the longest observation time was 1 month. Notably is that one of these animals conceived 
in the non-transplanted uterine horn at a time after UTx. The possible effect of 
cyclosporine in preventing rejection of a uterine allograft was also examined in a mouse 
model of UTx (83). In that study, a semi-allogeneic transplantation situation existed with 
the uterus donors being of C57BL/6 strain and the recipients being F1 hybrids of that 
strain combined with the CBA/ca strain. The uterus was heterotopically transplanted, with 
the vascular anastomosis sites being on the aorta and vena cava. Cyclosporine was 
administered through mini-osmotic pumps that were placed sc at dorsolateral aspect of 
the thorax. The cysclosporine dose of 10 mg/kg per day resulted in blood concentrations 
of around 200 ng/ml, while the high dose of 20 mg/kg per day gave a wider variation of 
blood levels, ranging from around 300 to over 1000 ng/ml. Although the doses 
cyclosporine used in that study were high, they were unable to prevent rejection-
associated changes of the graft at assessment 10 days after transplantation in that mouse 
model. Thus, normal gross morphology was evident but histology revealed a moderate 
increase in infiltrating leukocytes. Our laboratory has also conducted one study with 
cyclosporine as monotherapy in the rat allogeneic UTx model (84). In that study, 
cyclosporine was administered by daily sc injections of 10 mg/kg and the follow up time 
was 7 days post UTx. The gross morphological examination indicated some rejection, 
since a slight uterine enlargement was seen in some animals. Histology showed focal 
degenerative changes within the endometrium and also scattered lymphocytes in the 
myometrium and it was concluded that cyclosporine could suppress rejection to a large 
degree. 
 
Around 10 years ago, tacrolimus was introduced as the second clinically used calcineurin 
inhibitor in transplantation surgery. This substance is extracted from the fungus 
streptomyces tsukubaensis and its action is bind to specific FKBP12 receptors and 
thereby preventing activation of synthesis of IL-2, IL-3, interferon (IFN) gamma and also 
some other cytokines. Tacrolimus is now used more and more in clinical transplantation. 
Thus, the most common combination of immunosuppression used in transplantation is 
today tacrolimus together with mycophenolate and prednisolone.  
 
In the present study it was tested whether immuosuppression by tacrolimus as a 
monotherapy could inhibit uterine rejection in an allogeneic UTx model in the rat. The 
study was carried out with Brown Norway rats as uterus donors and Lewis rats as uterus 
recipients. This combination of organ donor and organ recipient represents a fully 
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allogeneic transplantation situation which would be similar as transplantation between 
unrelated humans. There were two sham-groups included in the study as control groups. 
One sham-group was medicated with tacrolimus but did not undergo surgery and the 
other group did only go through laparotomic surgery, which was designed to in some way 
mimic the UTx surgery. All the 4 groups had uteri of the Brown Norway strain but in the 
sham-groups as the native uterus and in the two UTx groups, as the grafted uterus. 
Surgery was conducted with isolation of the common part of the uterus and one uterus 
horn on a vascular pedicle and with transplanting this to the recipient after hysterectomy 
in that animal. Vascular anastomosis was on the common iliac arteries and veins. The 
results were evaluated by histology, immunohistochemistry and by measuring expression 
levels of several mediators that are related to inflammation/rejection and/or implantation. 
 
 
Results 
In this study, a total of 14 animals had to be used to achieve 12 transplanted animals with 
six of those belonging to the tacrolimus-treated group and six to the non-treated group. 
Tacrolimus was administered by mini-osmotic pumps at a dose of 0.5 mg/kg per day and 
this resulted in blood concentrations of the range between 1.2 and 6.3 ng/ml. The viability 
of the uterus and the histology as well as mRNA-levels of mediators were evaluated 14 
days after surgery. 
 
Uterine allografts not receiving the immunosuppression showed clear macroscopic signs 
of rejection. This was also confirmed in light microscopy, where wide-spread necrosis 
with only a brim of remaining muscular tissue was seen. The T-cell contents were 
difficult to assess in the non-treated UTx group because of necrosis. These histological 
changes differed completely from those of the native uterus of the control groups and the 
uterine allograft of the tacrolimus-treated group, as further described below. The non-
tacrolimus treated transplanted group showed high levels of IL-1 and these levels were 
higher than in all other groups. Similar results were shown for IP-10. There were lower 
levels of galectin-1 in the uteri of non-treated transplanted group, as compared to the 
tacrolimus-treated UTx group and in that of the sham-group treated with tacrolimus. 
 
The gross morphology and light microscopic picture of the uteri of the transplanted group 
given tacrolimus were similar to the control uteri. Immunohistochemistry showed low 
numbers of lymphocytes in the native uteri of the sham groups. Similar to the control 
grafts, allografts in the animals treated with tacrolimus had a very low number of T-cells 
except in 2 out of 7 transplants, where increased numbers of CD8 positive T-cells were 
found.  
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Comments 
This is the first study, which has thoroughly investigated the role of the calcineurin 
inhibitor tacrolimus in the rat UTx model. As stated above, our group has previously 
investigated whether cyclosporine can be used as a single immunosuppresive agent after 
UTx both in the mouse (83) and in the rat (84). Those studies found that even very high 
doses of cyclosporine were unable to effectively suppress uterine rejection in the mouse 
(83). It should be mentioned that the mouse UTx strain combination was a semi-
allogeneic grouping and the rejection potential may not have been full. In the rat (84), the 
lower of the doses of cyclosporine (10 mg/kg per day) than that was used in the mouse 
study (6), could almost completely suppress rejection when assessed after 7 days. 
 
In comparison to these studies on cyclosporine after allogeneic UTx, the dose of 
tacrolimus used in the present study was much lower on a per body weight calculation. 
This is in accordance with the recommendations of medication to prevent organ rejection 
after transplantation in the human, with a recommended dose of below 5 mg/kg per day 
for cyclosporine and doses up to 0.5 mg/kg per day for tacrolimus. 
 
The major finding of the present study was that tacrolimus, as a single 
immunosuppressive agent and at a low dose, is able to effectively prevent graft rejection 
in the rat UTx model. This finding may suggest that the uterus is not a highly 
immunogenic organ or that tacrolimus is especially suitable as an immunosuppressive to 
prevent rejection of a transplanted rat uterus. In studies of composite tissue 
allotransplantaion in the rat model (85, 86) it was shown that tacrolimus prolonged graft 
survival only if it was given at high doses (2-8 mg/kg/day) or if it was used in a 
combination therapy with other drugs such as 15-deoxypergualin (87). 
 
The analysis of mRNA levels of implantation-related markers included several key 
mediators. Differential expressions between the groups were seen for three markers. The 
pro-inflammatory cytokine IL-1 was markedly upregulated in the rejecting allograft and 
low in the other groups. This result is in accordance with the histology, showing 
inflammatory and necrotic tissue in the samples. It was reassuring to find that the IL-1 
levels in the tacrolimus treated and transplanted group were not elevated. This result is 
similar to that when cyclosporine was evaluated in the same model but with a shorter (7 
days) observation time (84).  
 
In the present study, also IFN gamma-induced protein-10 (IP-10) was evaluated, and this 
marker had not been tested in any animal model of UTx before. This cytokine is secreted 
by many cell types in response to stimulation by IFN gamma and it serves many actions 
including chemattraction for monocytes/macrophages and T-lymphocytes, promotion of 
T-cell adhesion and regulation of angiogenesis (88, 89). Importantly, this cytokine is also 
involved in remodulation and regulation of immunecells in the endometrium (90) and it 
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may thereby be of physiological significance for provision of an endometrium that is 
optimal for implantation. Implantation is a physiological process that is tightly regulated 
by the local immune system (91) and it has also been implicated that a small boost of 
local inflammation at the implantation site may enhance the implantation capacity (92).  
 
The implantation-related marker galectin-1 was also assessed. The levels of mRNA for 
galectin in the tacrolimus-treated and transplanted group were in the same range as in the 
control groups, which would indicate that the implantation potential of these animals 
would be normal. 
 
The results of the study, showing that tacrolimus is able to suppress rejection is 
promising, towards further studies on fertility potential in the allogeneic rat UTx model. 
However, it should be mentioned that these studies in the rat could not directly be 
extrapolated to other species, since certain inter-species differences may exist. We have 
experienced in our primate model of the baboon that single tacrolimus administration is 
not enough to prevent graft rejection of the uterus in an allogeneic UTx model (93) .  
 
 
Paper IV 
 
Background 
An important issue in all types of organ or tissue transplantation is to be able to detect 
rejection at an early stage. The rejection process depends on recognition by the host of the 
transplanted organ as non-self and several lines of studies indicate that parts of a graft are 
not uniformly attacked at rejection.  
 
The clinical presentation of rejection is generally divided into the three phases: 
hyperacute rejection, acute rejection and chronic rejection (94). The hyperacute rejection 
generally starts within hours after transplantation and is dependent on already formed 
cytotoxic antibodies that recognize histocompatibility complex 1 or blood group antigens 
on the endothelial cells of the microvasculature of the organ (45). This will lead to 
endothelial damage, with secondary thrombosis and blood flow obstruction through the 
organ.  
 
The dominant form of rejection and what is commonly referred to as organ rejection is 
termed acute allograft rejection. The first episode of this type of rejection generally 
occurs within the first 6 months after transplantation, with clinical signs being low grade 
fever and graft dysfunction. The basis for this acute rejection is recognition by the 
recipients CD4 T-lymphocytes of non-self antigens on any cell type of the graft. A 
complex immunological interplay will eventually lead to infiltration of inflammatory cells 
into the tissue, which in the end can lead to apoptosis and necrosis of organ cells. Thus, it 
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is of importance to detect these early events of acute rejection so that the rejection process 
can be reversed. 
 
The third part of graft rejection is the chronic rejection (95), which occurs in most 
transplanted organs as a very slow but progressive process. The mechnaisms behind this 
type of rejection is not well understood, but the end result of proliferative lesions in the 
microvasculature that leads to stenosis, is well described. 
 
As mentioned above, in the events that rejection is detected early and when it is only a 
mild inflammation, the immunological attack against the grafted non-self tissue can be 
reversed by modulation of immunosuppression. This is usually accomplished by 
increasing the doses of the calcineurin inhibitor used in the protocol, increasing cortisone 
doses or using anti-thymocyte globulin or similar induction therapies for a short while 
(96). Thus rejection does not mean an irreversible failure of the organ. 
 
In transplantation of organs that faces the exterior of an individual, detection of rejection 
may be available by biopsy. Thus, skin biopsies could be used for composite allografts 
such as the hand. Concerning internal organs, such as the kidney, the liver and the heart, 
these are not easily accessible and invasive biopsy procedures may be needed. An 
advantage of the uterus is that it is a semi-external organ and that all the parts are inside 
the body but with the access to the cervix in the upper part of the vagina and to also the 
endometrial cavity through the external os of the cervix. A small part of the upper part of 
the vagina may also be from the graft, and this could possibly be available for biopsies. 
 
There have been some studies looking at the uterine rejection after UTx, both by gross 
morphology and histology (97) as well as by detailed immunohistochemistry to quantiate 
different leukocyte subtypes (98) in the mouse UTx model. In the latter study, involving 
uteri from BALB/c mice transplanted into C57Bl/6 recipients, the leukocyte population 
was investigated at day 2, 5 and 10 after transplantation. The native uterus was kept as an 
internal control, to be able to compare the leukocyte population of the graft and the native 
uterus. The main findings were that the neutrophils were increased in the myomerium 
from day 5 and in the endometrium from day 10. The increase of T-cells followed a 
similar time-course, while the macrophages were increased already at day 2. Thus, both 
these studies in the mouse UTx model provide the first important background data 
concerning the time course of rejection of a transplanted uterus in any animal model. 
However, these studies only examined the endometrium and myometrium in cross 
sections of the uterus and concerning the myometrium, this is not a readily available site 
to acquire tissue biopsies for rejection diagnosis. Moreover, the study indicated that there 
may be time-related differences between inflammatory influx into the myometrium and 
the endometrium and this fact may indicate that uterine rejection is not a uniform 
phenomenon that occurs simultaneously in all compartments of the graft. 
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In the present study, an allogeneic model with Lewis rats as uterus donors and PVG rats 
as uterus recipients were used. This strain combination represents a fully allogeneic type 
of transplantation. It is known that there exist cycle-dependent variations in leukocyte 
distribution throughout the estrous cycle of the rat (99) but that a pseudopregnant state 
represents a stage of relative stability regarding leukocyte density. Consequently, the 
donors and recipients were synchronized by induction of pseudopregnancy to achieve 
similar distribution of white blood cells. The transplantation was done by an orthotopic 
approach, where hysterectomy was performed in the recipient and the vascular 
anastomosis was performed on the common iliacs. Initially, a pilot study of a few animals 
was conducted to examine when the first morphological signs of rejection was evident in 
this rat UTx model and it was then decided to include second look laparotomy at either 
day 4 or 7. Samples were obtained both from the uterus, from the cervix and from the 
blood vessels to examine different sites. Morphological analysis was done by an expert 
pathologist with long experience in clinical diagnosis of organ rejection. 
 
 
Results 
The success rate of surgery was somewhat lower than in earlier studies and 25 animals 
had to be operated to achieve 15 transplanted animals that were used for morphological 
evaluation of the grafts. The losses of the 10 animals were due to thrombosis or bleeding. 
The recipient surgery time was around 180 minutes. The morphology of native uteri that 
was removed at transplantation was used as control. In morphological analysis of the 
myometrium and endometrium of these specimens, only low numbers of inflammatory 
cells were present, although in occasional uteri there existed dense infiltrates of 
eosinophils. In conjunction with these eosinophilic infiltrates, apoptotic figures were 
seen. Similar findings were seen in the cervical biopsies. 
 
At day 4, the grafts had normal tissue architecture apart from that the endometrial glands 
showed some degree of dilation and that neutrophils were seen within the glands. 
Inflammatory cells were abundant within in the blood vessels of the uterine body, but the 
inflammatory infiltrate was only minor within the stroma of the myometrium. Another 
distinction from the native controls was that the number of eosinophils was very low in 
all specimens. In the cervix of the day 4 uteri, the squamos epithelium was found to be 
thinner and there were also an increased number of inflammatory cells around the glands, 
which were dilated and filled with neutrophils. At this stage, the vessels showed signs of 
focal inflammation and in some cases thrombi formations were seen. 
 
At day 7 after transplnatation, the signs of rejection were more general. The uterine 
architecture was fairly well-preserved but damage to the endometrium was evident by 
focal loss of luminal endometrium and reduced number of glands. The inflammatory 
38 
 
is of importance to detect these early events of acute rejection so that the rejection process 
can be reversed. 
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changes of the uterine body were now evident in all sites with presence of transmural 
inflammation. In the cervix, the most uniform signs of rejection were evident in the 
stroma and blood vessels, showing increased number of inflammatory cells. The 
squamous epithelium of the cervix was in some animals almost normal, while other 
showed a thinning or a loss of this compartment. The major blood vessels from the graft 
showed clear signs of subendothelial inflammation and formation of thrombi. 
 
 
Comments 
This is the first study which has thoroughly looked at specific changes at uterus rejection 
in the rat UTx model. Importantly, the study demonstrates that rejection is a fairly 
uniform entity with changes seen both in the cervix and in the uterus. Mild inflammation 
was seen already 4 days after transplantation. At this stage there was no loss of normal 
tissue and this stage would most likely correspond to a time of early clinical rejection, 
when increase of anti-rejection drugs could prevent further rejection.  
 
It should be noted that the results of the study indicate that also the cervix is a suitable site 
to assess rejection. The changes were most stable within the cervical stroma, while the 
epithelium of the cervix showed an inconstant response. This finding would indicate that 
in a clinical situation it would not be accurate to determine the rejection state of a 
transplanted uterus only by ocular inspection of the cervix by the naked eye or by 
colposcopic examination. In the published human UTx case (58), the authors report that 
the cervix was dusky-coloured just before removal of the necrotic graft. No details are 
given on the histological findings of this graft. 
 
This seemingly favourable situation of diagnosis of rejection by a deep cervical biopsy, 
that includes stroma and intracervical blood vessels, may be important in clinical 
situations since the cervix is available for biopsies in an outpatient gynecological setting 
without any need for local anesthesia. Further studies should be done to grade rejection at 
different sites in other animal models of UTx models in order to understand what the 
most proper place of biopsies in a clinical setting is. The recent study on allogeneic UTx 
in the baboon (93), also indicates that the cervix is an appropriate site for attainment of 
biopsy in order to examine if any rejection reaction is present with the uterine graft.  
 
 
Paper V 
Background 
During recent years several studies on UTx have been published. Most of these have 
examined functionality in terms of presence of viable myometrium and endometrium (62) 
as well as of menstruation in the cases of non-human primate species (100). 
Demonstration of pregnancy with live birth is obviously the ultimate goal of UTx. Thus, 
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pregnancies in syngeneic settings have been accomplished in the mouse (59, 60) and in 
the rat (Paper II). After autologous transplantation, pregnancies were accomplished in the 
sheep (77) and just recently also in the cynomolgus macaque (101).  
 
The major question in UTx research is however, if also an allogeneic uterine graft can 
function in terms of implantation of an embryo and support of an ongoing pregnancy. 
Such pregnancy would be subjected to several factors that may negatively affect the 
pregnancy outcome. Some of these factors, such as surgical trauma, altered blood supply, 
denervation, lack of lymph drainage and ischemia-reperfusion injury would also be 
present after syngeneic or autologous transplantation. The added factors in the allogeneic 
setting of UTx are effects of immunosuppressants and possible presence of low grade 
rejection that is not properly suppressed by the immunoactive drugs. 
 
The present study represents the first attempt in the rat to test whether pregnancies also 
can occur in an allogeneic UTx situation. Previously, allogeneic UTx had been done 
before the introduction of calcineurin inhibitors as effective immunosuppressants. In 
these experiments of avascular UTx in the rhesus macaque (102) and as well as vascular 
UTx in the dog (103), the immunosuppressants that were used were not able to prevent 
rejection and the uteri became non-functional and later necrotic. The calcineurin inhibitor 
cyclosporine was used in a rabbit model of nonvascular UTx but the results of that study 
was not encouraging (104). Recently, allogeneic UTx with tacrolimus was tested in the 
rabbit, but with poor survival of the animals (105). The pregnancy potential could not be 
tested in that study because of the short survival time of the animals. 
 
In the present study, a fully allogeneic model of rat UTx was used with the uterus donors 
being of the Dark Agouti strain and the recipient being of the Lewis strain. For mating 
and to prove fertility, males Sprague-Dawley rats were used. The surgery involved an 
orthotopic placement of the allograft with, apart from vascular connections end-to-side on 
the common iliac vessels, also anastomosis between the right uterine horn of the graft and 
likewise on the vaginal rim. The surgical procedure was essentially the same as used in 
Paper II.  
 
 
Results 
In a first set of 10 animals, the pelvic and the vascular anatomy of these strains were 
specifically studied and the surgery was optimised. There was a learning curve with 
deaths during surgery of animal 4-6 but with the last 4 pre-study animals surviving until 7 
days after surgery with adequate gross morphology of the graft. There were two control 
groups included in the study. These consisted of sham-surgery with no tacrolimus or 
sham-surgery with tacrolimus. The animals received tacrolimus by a mini-osmotic pump 
and the tacrolimus blood levels were in the range between around 5 and 25ng/ml. 
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The pregnancy rates were similarly in the UTx and tacrolimus-treated group and in the 
sham and tacrolimus-treated group. There was a tendency to somewhat higher pregnancy 
rate in the sham-group with surgery but not receiving tacrolimus treatment. In the 
experiments, caesarean section was done at day 17. The number of foetuses were similar 
in the 3 groups, but with a variation between 0-5. It should be noted that the rate of 
resorbed pregnancies were higher in pregnant rats of the UTx group receiving tacrolimus 
compared to the controls.  
 
 
Comments 
This study represents the first study ever that has demonstrated fertility after allogeneic 
UTx. As stated above, trials of allogeneic UTx with immunosuppression had been 
performed in the dog (103), rabbit (82) and the rhesus macaque (102). In recent times, 
monotherapy with tacrolimus after allogeneic UTx has been tested in the baboon (106) 
and in the rabbit (105). In these latter, studies the drug was administered daily by the oral 
or intramuscular route. Moreover, daily sc administration of cyclosporine was tested in 
the allogeneic UTx model in the mouse (83). In the present, study mini-osmotic pumps 
were used for drug administration. This way of administration to the extracellular space in 
the subcutis is based on the principle that a constant dose of drug is delivered 
continuously by osmosis and that this will maintain the target therapeutic level at a fairly 
constant concentration.  This system has been extensively tested in the rat for 
administration of pharmacological agents such as cyclosporine (107, 108) and for 
administration of hormones such as estradiol (109, 110)  
 
The reason for terminating the pregnancies at day 17 of pregnancy was both to follow the 
ethical application protocol, with a step-by-step approach enabling demonstration of 
pregnancy before evaluating birth and offspring, and with the added benefit of enabling 
investigation to assess the number of resorbed pregnancies.  
 
The somewhat higher rates of resorbed pregnancies in the uterus transplantation 
UTxgroup as well as the low pregnancy rate in the groups receiving tacrolimus indicate 
that this immunosuppressant may in some way negatively affect the pregnancy potential 
of the rats. In addition, the ischemia reperfusion injury occurring during the time of 
revascularization of the graft can affect the pregnancy potential. Other factors related to 
the surgery, as stated in comments to Paper II, can also decrease the fertility rate in these 
animals. 
 
 After presenting this study, demonstrations of pregnancy after allogenic UTx in the sheep 
was reported by Ramirez and coworkers (111) and thus this initial observation have been 
extended to other animals. The results of the present study represents the first 
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demonstration of pregnancy after allogeneic UTx in any species and further studies have 
to follow to also look at live offspring and development in allogeneic UTx models of 
different species.  
 
 
Paper VI 
 
Background 
During the last decade, much research efforts have been made in the area of UTx, with 
specific studies aiming at developing and optimizing procedures such as surgery (59, 100, 
112, 113) and ischemic preservation (114, 115). In many of these studies, an important 
factor to test has been to assess whether the tissue is viable or not. Thus, many studies 
have relied on histology on the light microscopic level (62, 116), but this is most likely a 
fairly insensitive test of the normality of the tissue, since early signs of cell death is not 
detected. In one study on human uterine tissue, electron microscopy was used to assess 
the viability of the tissue after 24h of cold ischemic preservation in various solutions (71), 
and this method was able to detect nuclear changes if preservation had occurred in a non-
preservation solution. In the same paper, contractility was used to asses if the tissue was 
functional after a long period of ischemia. However, the function of the uterus is naturally 
not only to contract but to be able to host a pregnancy and to provide the optimal 
conditions for implantation and placentation. Thus, the normality of these procedures 
have been demonstrated after syngeneic UTx in the mouse (60, 117) and the rat (Paper 
II). Moreover, autotransplantation of the sheep uterus and adnexa (118), with an extended 
warm ischemic time of 3h, was compatible with normal pregnancies in this animal 
species with a uterine size of similar size as the human. Recently, one live birth was 
shown after autologous UTx in a non-human primate species (101). 
 
The situation after allogeneic UTx is naturally more complicated than after syngeneic or 
aoutologous UTx, since also immunosuppression and rejection mechansims are added 
factors that may disturb any pregnancy. There are only two studies that so far have 
demonstrated pregnancy in this allogeneic setting. In the study by Ramirez and coworkers 
(119), three pregnancies were initially accomplished in their sheep UTx model. The 
pregnancies were established after embryo transfer. One pregnancy was established in the 
oviduct and out of natural reasons this pregnancy could not proceed. Another of the three 
pregnancies ended in miscarriage. The third pregnancy continued well into the third 
trimester, when a lamb of appropriate size was born. However, life support was only 
continued for a short term. 
 
In the present study we evaluated the postnatal condition of rats born from allogeneic 
uterus graft under immunosuppression. Lewis rats served as donors and PVG rate were 
recipients. The transplantation was by microvascular anastomosis on the common iliacs 
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and the immunosuppression was by tacrolimus. Two months after transplantation and 
initiation of immunosuppression by tacrolimus, the transplanted rats were placed for 
mating and pregnancies were recorded. Two sham-groups were included, one which was 
subjected to sham-surgery and another which underwent sham surgery under tacrolimus. 
The pregnancies went to term and the mature fetuses were delivered by caesarean section.  
 
 
Results 
The pregnancy rate was similar in all the three groups with 70% in the sham-surgery 
group, 80% in the sham group treated with tacrolimus and 50% in the UTx group treated 
with tacrolimus. It was a fairly large variation in the number of pups in the three different 
groups, but the birth weight was similar and around 5g in all groups. The female offspring 
groups were similar during comparison during 100 days. However, the male offspring 
from the UTx were a little heavier at this stage. 
 
 
Comments 
This is the first study ever that has evaluated the birth weight and the postnatal 
development of offspring after allogeneic UTx. The offspring has been subjected to many 
unphysiological factors that may affect their growth in the transplanted uterus but which 
also may change the growth after birth. The transplanted uterus has been subjected to 
tissue trauma during the surgical procedure of transplantation and ischemic events may 
also affect its state after transplantation. After transplantation, the blood flow to the 
transplanted uterus could be affected due to inability of the anastomosis site to expand in 
parallel to the hemodynamic changes of pregnancy. Moreover, it is uncertain whether 
lymphatic drainage and nerve supply of a transplanted uterus are reestablished. All the 
factors mentioned also exist after syngeneic or autologous UTx and the demonstration of 
pregnancy in the syngeneic rat UTx model (Paper II) and after autotransplantation in the 
ewe (77) and the cynomolgus macaque (101) points towards that the UTx methodologies 
that have been developed are satisfying formal surgical standpoint. In the present study 
also immunosuppression and possible low grade rejection are added factors that may 
negatively influence a pregnancy.  
 
The use of tacrolimus to prevent rejection in the allogeneic model had proved to be 
effective in the experiments of Paper III, although the time period of that paper was only 
2 weeks. In the experiments involving allogeneic UTx in the sheep and offspring, 
cyclosporine monotherapy was used (119). 
 
The results of the present study point towards a normal development of the rats 
concerning the first 3 months. However, an interesting observation which should be 
followed up in further studies is that the male rats showed somewhat greater weight gain. 
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The explanation to this is unclear and naturally a larger cohort of offspring is necessary to 
establish whether this is a real difference. Further studies should also be made to assess 
these offspring up into adulthood concerning not only growth but several physiological 
parameters. 
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negatively influence a pregnancy.  
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effective in the experiments of Paper III, although the time period of that paper was only 
2 weeks. In the experiments involving allogeneic UTx in the sheep and offspring, 
cyclosporine monotherapy was used (119). 
 
The results of the present study point towards a normal development of the rats 
concerning the first 3 months. However, an interesting observation which should be 
followed up in further studies is that the male rats showed somewhat greater weight gain. 
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The explanation to this is unclear and naturally a larger cohort of offspring is necessary to 
establish whether this is a real difference. Further studies should also be made to assess 
these offspring up into adulthood concerning not only growth but several physiological 
parameters. 
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General discussion 
 
The first human transplantation case was performed in Saudi-Arabia in year 2000. This 
case was published in year 2002 (58) and involved transplantation of a uterus from a 46 
years old live donor to a 26 years old patient who had lost her uterus some years earlier at 
emergency peripartum hysterectomy. The procedure to recover the uterus was similar to a 
hysterectomy, but involved some dissection of the uterus on the donor. Nevertheless, 
fairly short lengths of the uterine veins and arteries were attached the uterus that was 
harvested and back-table preparation had to involve elongation of both the uterine veins 
and the arteries with saphenous vein grafts. The surgery in the recipient went uneventful 
but the uterus had to be removed after 3 months because of uterine necrosis.  
 
Many researchers and clinicians throughout the world thought this was a premature 
attempt to transplant a human uterus since the research group had no previous basic 
research background concerning UTx in animals and several major issues were not 
properly examined prior to this extensive surgical procedure in the human. The issues that 
should be investigated in animal settings before clinical introduction relates to the 
surgical techniques used at uterus recovery from the donor, the surgery of the recipient, 
the vascular anastomosis, the tolerability to ischemia and reperfusion, suitable 
immunosuppression and fertility in a transplanted uterus. Many of these aspects were 
investigated in the present thesis 
 
The specific results of each paper are commented in the Results and Comments section of 
this thesis. In this section I have chosen to discuss some general issues, of relevance to the 
results that were obtained and to future directions of research concerning UTx in the rat 
model. 
 
 
The rat as an experimental animal 
The research group that I belong to has developed several animal models in a research-
based approach towards human uterus transplantation. During recent years the rat has 
proved to be the most suitable small animal model and we have complimented studies in 
the rat with those in non-human primate species (120, 121). Other research groups in the 
world have mainly used the sheep (122), the pig (6, 61) and the rabbit (105). The focus of 
this thesis was to develop the rat model for uterus transplantation research. 
 
There are many possible advantages with the rat model. The laboratory rat is one of the 
most commonly used experimental animals. It serves as a model for the analysis of a 
number of important biomedical issues such as metabolism, organ transplantation and 
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immunology. Since the knowledge about the rat is vast it has a unique advantage as 
model system for human diseases and also human surgical interventions.  
 
The size of the rat makes it ideal for physiological manipulations and also for surgery, in 
comparison to the much smaller laboratory mouse.  
 
Most laboratory rats belong to the Norway rat (Rattus Norvegicus). The Norway rat was 
one of the first mammalian species to be domesticated for scientific purposes. Today it is 
the second most widely used experimental animal in biomedical research, with only the 
mouse being used more frequently. An advantage of the rat is the existence of genetically 
defined strains. Concerning transplantation research, both research on various organ 
transplantation and immunology has established the rat as one of the favourite research 
tools. The major histocompatibility complex (MHC) has been investigated in the rat and it 
is now called RT1. This RT1 system is located on chromosome 17 (123) and has recently 
been further characterized (124). Of importance is of course the T-cell composition of the 
rat immune system, since T-cells are instrumental in rejection. There is presence of both 
CD4 positive and CD8 positive cells and importantly IL-2 is involved in the T-cell 
development also in rats (125). This is of importance since one effect of calcineurin 
inhibitors is to suppress IL-2 synthesis. There exist specific strains of rats that 
spontaneously acquire diseases such as hypertension, stroke, insulin dependent diabetes, 
spontaneous tumors and arthritis. 
 
It has been more difficult to develop efficient transgenic technology in the rat as 
compared to the mouse. This technical problem has recently been overcome and knockout 
technology and transgenic overexpression of rats is now also possible. Some good 
features of rat biology in comparison to mouse models are more human like physiological 
responses to some diseases such as arthritis, cancer and hypertension. Moreover, the 
larger size makes it more suitable for surgical manipulation and repeated blood sampling. 
These latter things will of course have relevance to transplantation research.  
 
The first method for transplantation in the rat was cardiac transplants in 1964 (126, 127). 
In this initial model, the heart was heterotopically transplanted by connecting the 
recipient’s abdominal aorta and the donors descending aorta using end-to-end technique. 
Later on, this transplantation method was modified to use the abdominal vessels (128). 
During recent years, the cardiac transplantation model that has been most widely used is a 
technique for auxillary transplantation in the rat, where the native heart is kept in place 
(129). In the same paper, an auxillary heart and lung transplantation was published. Just 
one year later, an orthotopic non-auxillary heart and lung transplantation was published, 
but more than 300 transplant trials were done before any survival of the rat was 
accomplished (130). The technique has then been modified and the survival rate is now 
over 80% after orthotopic lung and heart transplantation in the syngeneic rat. The UTx 
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models, as developed in the present thesis (Paper I, II), has naturally benefitted in their 
development from these early pioneering studies in experimental transplantation.  
 
During recent years rat models for liver transplantation (131) and intestinal 
transplantation (132) have been developed and successfully been used to study several 
aspects of the transplantation procedure. 
 
 
Syngeneic UTx and fertility 
Experimental syngeneic UTx models can be used to separate the effects of surgery, 
ischemia and the new anatomical placement of a transplanted uterus from effects of 
rejection and immunosuppressive agents, which add to the complexity of allogeneic 
transplantation. The donor and recipient in syngeneic transplantation will be virtually 
genetically identical, since they would be of the same inbred strain of an experimental 
animal, or in the human be identical twins.  
 
Most inbred animal strains exist in the rodent animal species. The mouse has the 
advantage over the rat, since it is easy to gene-modify mice and there is a great abundance 
of recombinant proteins and monoclonal antibodies in this species. The weight of the 
adult mouse (20-25g) is conversely a disadvantage in surgical procedures such as 
transplantation, in comparison to the adult rat (Paper I-VI) with a weight at least 4 times 
that of the mouse. 
 
The first rodent model, which was thoroughly explored concerning UTx and fertility, was 
the mouse model. In the primary mouse UTx study, F1 hybrids of females of the inbred 
strains C57BL/6 and CBA/ca were used (59) and the surgery included a model of 
heterotopic UTx, where the native uterus was kept in situ as an internal control. The 
transplantation was performed by an end-to-side anastomosis of the vena cava and aorta 
of the graft and the recipient. Great microsurgical skills were needed since the lumina of 
the aorta and vena cava were only about 0.7 mm and 1.5 mm, respectively. These 
microsurgical skills could not be fully replicated by others and that is one reason why rat 
models of UTx were developed (Paper I, II). In the initial model the uterine cervix of the 
graft was positioned intraabdominally to avoid possible infections through contact with 
the exterior. In this initial mouse study (59), the fertility potential was tested only in one 
of the experimental animals. At about 2 weeks after UTx, blastocysts were retrieved from 
a naturally mated mouse. The blastocysts were transferred to the uterine cavity of both the 
transplanted graft and the native uterus, after preparing the transplanted mouse for a 
pseudopregnancy, with mating it with a sterile male mouse. The embryo transfer (both to 
native and grafted uterus) was performed via a midline laparotomy and then 
transmyomterially through a thin cannula. Three blastocysts were placed inside each 
uterus cavity and the animal was euthanized, 10 days after embryo transfer. One foetus 
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was seen in the graft, which also had an absorbed pregnancy. The paper (59)], represents 
the initial t proof-of-principle study in relation to the fertility and UTx.  
 
In a follow-up paper, the UTx procedure was modified so that the cervix graft was 
connected to the skin of the mouse to create a cervical-cutaneous stoma (60), in order to 
avoid uterine swelling, secondary to accumulated intraluminal mucus, which was seen in 
the initial mouse study. This model is similar to the rat UTx model of Paper I, where also 
the vascular anastomosis sites were the infrarenal abdominal aorta and caval vein.  
 
The pregnancy rate of transplanted animals, carrying both native and grafted uteri, were 
compared with sham-surgery animals. The mice received embryos during the interval 
from 1-3 weeks after transplantation, with blastocysts (3-6 to each uterus horn) inserted 
transmyometrially (133). The first set of animals was evaluated concerning fertility at 2-3 
days before anticipated parturition. The pregnancy rate was similar in the native (75%) 
and the grafted (66%) uterus of the transplanted animals as compared to control animals 
(66%). This can be compared to a pregnancy rate of 47% in the syngeneic rat UTx group 
of Paper II. It should be noted that Paper II involved spontaneous mating and this mouse 
study (60), involved pregnancies after embryo transfer. Importantly, the median numbers 
of foetuses in these pregnant mice (60) pregnant animals were similar in the groups with 
4, 4 and 3 in native, grafted and control uterus, respectively. The mouse study also 
examined the weight of the foetuses at day 18 and that of the placenta, with similar 
weights recorded in all groups. In the second series of experiment in the mouse UTx 
paper (60), pregnancies went to full term and pups were delivered spontaneously, but 
caesarean section delivery was attempted from the grafted uterus. In some cases delayed 
spontaneous deliveries occurred from the graft. An explanation for the delay may be 
mechanical factors, with slow cervical dilation at the point of passage through the skin 
but poor nerve supply of the transplanted uterus and the heterotopic position of the organ 
may also influence the results. In Paper II, the rate of successful deliveries was markedly 
lower than in the control group and denervation of the uterus may also be one factor that 
influence the results in that orthotopic transplantation method.  
 
The postnatal and later growth of the mouse offspring was followed for 8 postnatal 
weeks. The growth was normal, as compared to animals from native uteri and from 
control animals. Concerning the results of Paper II, growth trajectory of the live births 
from the sham-surgery group and the UTx group was similar, though any firm 
conclusions should not be made since the number of live births in the UTx group was 
very low. In order to rule out that the native uterus of the mouse would influence the 
pregnancy potential of the grafted uterus, some animals underwent UTx with the native 
uterus removed (60). This is a situation as in Paper II, but with the difference of 
placement of the grafted uterus at heterotopic and orthotopic positions, respectively. 
Pregnancies were seen in the mice that had no native uterus, showing that pregnancy 
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potential of the graft was independent on input from the native uterus. The fertility of 
offspring of both genders from the grafted uterus was normal and the second generation 
offspring from these mice showed normal birthweight (60). In addaition, one study in the 
syngeneic mouse model has demnostrated normal fertility also after preservation of the 
uterus in a cold environment, during the time from removal to transplantation (117)  
 
In Paper II, pregnancy potential of the syngeneic uterine graft, with one uterine horn 
excised, was compared to sham-operated rats that only underwent unilateral uterine horn 
excision. In the series of 19 animals in each group, pregnancy rate was similar with 11 
rats in the UTx group versus 12 in the sham-surgery group. The median numbers of pups 
were 3 in the UTx group and 3.5 in the sham group. However, as mentioned above the 
UTx group had lower rate of successful deliveries. An explanation to this may be a 
protracted labour in the transplanted uterus, caused by denervation. This assumption was 
based on a previous paper showing that the sensory innervation of the uterus is necessary 
for a normal delivery in the rat (134).  
 
The results of these syngeneic rodent UTx models, as discussed above, are important as 
the first demonstrations of the principle of fertility potential in a transplanted uterus. 
However, being rodent models, the experimental situation is certainly different from a 
human situation concerning surgery and also pregnancy length as well as placentation. 
Moreover, the extra strain of being an allogeneic graft has not been evaluated. This is 
further discussed below. 
 
 
Allogeneic UTx and fertility 
The allogeneic UTx situation is obviously more multifaceted than syngeneic and UTx, 
since the effects of rejection and immunosuppression also are factors that may affect the 
fertility potential of a transplanted uterus. 
 
The results of Paper V, was the first description of pregnancy after allogeneic UTx, which 
of course is an important proof-of principle. The surgical technique used in this study was 
modified from the syngeneic rat model (Paper II). The Dark Agouti (DA, RT-1a) uterus 
donors were operated by a midline laparotomy to surgically isolate the uterus, with the 
right uterine horn excised. The Lewis (RT1l) uterus recipienst were prepared for UTx by 
hysterectomy and dissections of the common iliac artery and vein on the right side were 
performed, to be used as vascular anastomosis sites. The immunosuppressant given to 
prevent uterine graft rejection was tacrolimus at a dose of 0.5 mg·kg-1·day-1. In addition 
to the transplanted group (UTx-Tac), two control groups were included in this study: 1) 
rats undergoing just sham surgery (hemihysterectomy; Sham) and 2) rats undergoing 
sham surgery and the same immunosuppressive protocol as the transplanted group 
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(Sham-Tac). In this Paper V, spontaneous mating occurred after introduction of 
experimental animals to males of proven-fertility. The number of foetuses and 
implantation sites were counted at the time of cesarean sections on pregnancy day 17. 
Pregnancy rates were slightly (but insignificantly, possibly due to the small sample size 
(n=19)) decreased in the groups undergoing immunosuppression: 62.5% in the UTx and 
tacrolimus treated group, 60% in the sham-group with tacrolimus treatment, as compared 
to 83% in the sham-surgery group. This study was only designed to prove that pregnancy 
was possible after allogenic UTx and to evaluate the possible impact on implantation rate. 
This is a step-by-step method we have used in studies on other aspects of experimental 
UTx.  
 
In the follow-up paper (Paper VI) Lewis (RT11) rats were used as donors and PVG 
(RT1c) rats as recipients. The pregnancy rates did not show any significant differences 
between the groups with 50% in the UTx and tacrolimus treated group, 80% in the sham-
group with tacrolimus treatment and 70% in the sham-surgery group, but the birth 
weights of the pups were similar in the groups. As shown in Paper VI, the growth of 
offspring from the experimental groups was similar in the control groups during the first 
months after transplantation. However, a small elevation in weight was seen in the male 
offspring of the UTx group with tacrolimus treatment at postnatal day 100. This should be 
explored further whether any progressive weight deviation occurs.  
 
There also exists some experience of allogeneic UTx in a larger animal. In 2011, another 
group reported two pregnancies and one birth after allogeneic UTx in the sheep (119), 
using a previously published surgical model (62). Via a small subumbilical incision, the 
uterus with short uterine vessel pedicles was retrieved from one animal and placed in 
another animal that underwent the same surgical treatment (62). The anastomoses 
technique used was end-to-end on the uterine arteries and veins and the vaginal vault of 
the graft was also end-to-end anastomosed to the vaginal rim of the recipient. The 
experiment involved allogeneic transplantations between Sudanese and Ethiopian breeds 
(119). However, it should be noted that sheep bred in farms may diminish the functional 
allogenicity of the transplantation (135) and it was not full reported concerning their 
allogeneicity. The recipients were treated orally with cyclosporine A and intramuscularly 
with prednisone, starting two days in advance of UTx. In the study prednisone treatment 
was discontinued after 2 weeks post-transplantation and satisfactory levels of 
cyclosporine were reached by day 5. Twelve animals underwent UTx with 8 surviving the 
procedure. Embryo-transfer was done in 5 animals with normal cyclicity and a normal 
graft at second-look surgery (119). Three pregnancies were reported. One pregnancy was 
an ectopic pregnancy requiring removal of the uterus, another resulted in fetal demise at 
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months after transplantation. However, a small elevation in weight was seen in the male 
offspring of the UTx group with tacrolimus treatment at postnatal day 100. This should be 
explored further whether any progressive weight deviation occurs.  
 
There also exists some experience of allogeneic UTx in a larger animal. In 2011, another 
group reported two pregnancies and one birth after allogeneic UTx in the sheep (119), 
using a previously published surgical model (62). Via a small subumbilical incision, the 
uterus with short uterine vessel pedicles was retrieved from one animal and placed in 
another animal that underwent the same surgical treatment (62). The anastomoses 
technique used was end-to-end on the uterine arteries and veins and the vaginal vault of 
the graft was also end-to-end anastomosed to the vaginal rim of the recipient. The 
experiment involved allogeneic transplantations between Sudanese and Ethiopian breeds 
(119). However, it should be noted that sheep bred in farms may diminish the functional 
allogenicity of the transplantation (135) and it was not full reported concerning their 
allogeneicity. The recipients were treated orally with cyclosporine A and intramuscularly 
with prednisone, starting two days in advance of UTx. In the study prednisone treatment 
was discontinued after 2 weeks post-transplantation and satisfactory levels of 
cyclosporine were reached by day 5. Twelve animals underwent UTx with 8 surviving the 
procedure. Embryo-transfer was done in 5 animals with normal cyclicity and a normal 
graft at second-look surgery (119). Three pregnancies were reported. One pregnancy was 
an ectopic pregnancy requiring removal of the uterus, another resulted in fetal demise at 
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105 days of gestation and the last pregnancy was in utero and developed normally. This 
resulted in delivery of a fully developed lamb at 138 days, via cesarean section.  
 
 
Future directions of UTx research in the rat model 
The results of this thesis have demonstrated that the rat UTx model is a reproducible 
model, which can be mastered by previously untrained microsurgeons and with fertility 
after spontaneous mating. During recent years also other animal models have been 
developed and importantly are the non-human primate models. However, these non-
human primate models are very costly and experiments may be difficult to design due to 
that there is a fairly large inter-individual variation in outbred settings. Thus, the rat and 
the mouse model may have their places in further UTx research. 
 
The importance of these rodent models of UTx will lay in that a larger number of animals 
can be used in an experimental design. Moreover, the restricted pregnancy time and the 
restricted time between generations make it suitable for research on reproductive factors, 
such as fertility after Utx. The studies in the thesis have shown that the surgery can be 
mastered well, both in the heterotopic (Paper I) and orthotopic (Paper II) UTx-model. 
However, the surgery could possibly be developed somewhat by further training and 
modification of the procedure, to increase the graft survival. Especailly in the allogeneic 
transplantations, initial graft survival has been modest (Paper IV). 
 
The most important aspect now in the rat UTx research should be to assess whether the 
offspring from uterus transplanted animals are fully normal. In Paper V, fertility was 
demonstrated after allogeneic uterus transplantation. In the follow-up paper (Paper VI) it 
was demonstrated that the birth weight was normal in the offspring from the transplanted 
group. However at 100 days of age, the offspring male rats from the transplanted group 
proved to be somewhat larger than the offspring from the control group (Paper VI). 
Naturally, weight is just one very crude variable of the rats and several aspects should be 
studied on these offsprings.  
 
In particularly, the placenta should be studied with histology and immunohistochemistry 
towards important placental proteins such as for example steroid receptors, steroidogenic 
enzymes and vascular markers. It is known that birth weight influences adulthood 
conditions and diseases such as the metabolic syndrome and cardiovascular diseases. The 
metabolism of the offspring could be studied at different ages of the animals. This could 
be done both by investigating the basal metabolism in metabolic cages. Moreover, 
glucose tolerance could be studied by clamp techniques to ascertain that these rats are not 
pre-diabetic. Another important factor is the body composition. A way to study this is by 
53 
 
dual energy X-ray absorbtion (DEXA) which can determine both lean body mass as well 
as fat mass. The basal metabolic status can also be evaluated by indirect calorimetry and 
oxygen consumption rate, usually performed in metabolic cages over 24 hours. 
 
Concerning cardiovascular monitoring, blood pressure should be measured at different 
ages and functional electrocardiography can also be done. It is known that calcineurin 
inhbibitors affects the kidney and the kidney function should also be evaluated. This can 
easily be accomplished in metabolic cages, where urine sampling can be arranged. The 
urine should be analysed in detail to describe ionic and possible altered protein 
composition, as well as creatinine levels. Since the allogeneic offspring have been 
subjected to immunomodulator drugs during their foetal development, thorough 
immunological tests should be done concerning both numbers and function of all different 
immune cell components. 
 
It could not be excluded that the development in an allogeneic uterus graft can affect the 
behaviour. There exist tests for both locomotor activity and anxiety in the rats and that 
could be used in these follow-up studies. It should also be ascertained that females and 
males have full fertility after allogeneic uterus transplant. This test should include normal 
mating experiments with males and females of proven fertility. 
 
When the animals are euthanized, several tissues could be collected for detailed 
histological analysis and immunohistochemistry. Important is to rule any increased rate of 
tumour development in tissues examined, but also to observe if any other structural 
changes are present. The especially important tissues would be the kidney, liver, heart and 
of course the reproductive tract. Aorta may also be of importance to examine to rule out 
the presence of aortic sclerosis. 
 
 
Concluding remarks 
 
These studies on UTx in the rat model represent the first detailed descriptive studies on 
UTx in this species and they have also advanced the UTx field further, especially 
concerning studies of allogeneic UTx. They should serve as the fundament for further 
studies, not just exploring the offspring, but perhaps also to further optimized 
immunosuppression and preservation conditions at transplantation. 
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